{
 "cells": [
  {
   "cell_type": "code",
   "execution_count": 6,
   "id": "superior-validation",
   "metadata": {},
   "outputs": [],
   "source": [
    "# %config Completer.use_jedi = False"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 17,
   "id": "fifty-register",
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "url_item_static.csv\n",
      "url_item_static.png\n",
      "url_item_static_total.csv\n",
      "url_item_static_total.png\n"
     ]
    }
   ],
   "source": [
    "!ls ../labtestonline_datasets/dataset_statics"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "id": "lonely-strengthening",
   "metadata": {},
   "outputs": [],
   "source": []
  },
  {
   "cell_type": "code",
   "execution_count": 1,
   "id": "generous-savannah",
   "metadata": {},
   "outputs": [],
   "source": [
    "import matplotlib.pyplot as plt\n",
    "import pandas as pd\n",
    "import numpy as np\n",
    "import tensorflow as tf\n",
    "import requests\n",
    "import json\n",
    "import sys\n",
    "import spacy"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 24,
   "id": "hispanic-expansion",
   "metadata": {
    "collapsed": true
   },
   "outputs": [
    {
     "data": {
      "text/plain": [
       "<matplotlib.image.AxesImage at 0x267dfe887f0>"
      ]
     },
     "execution_count": 24,
     "metadata": {},
     "output_type": "execute_result"
    },
    {
     "data": {
      "image/png": "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\n",
      "text/plain": [
       "<Figure size 4680x4680 with 1 Axes>"
      ]
     },
     "metadata": {
      "needs_background": "light"
     },
     "output_type": "display_data"
    }
   ],
   "source": [
    "img_dir = '../labtestonline_datasets/dataset_statics/url_item_static.png'\n",
    "plt.figure(figsize=(65, 65))\n",
    "img = plt.imread(img_dir)\n",
    "plt.imshow(img)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 25,
   "id": "mechanical-winter",
   "metadata": {
    "collapsed": true
   },
   "outputs": [
    {
     "data": {
      "text/plain": [
       "<matplotlib.image.AxesImage at 0x267da413cd0>"
      ]
     },
     "execution_count": 25,
     "metadata": {},
     "output_type": "execute_result"
    },
    {
     "data": {
      "image/png": "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\n",
      "text/plain": [
       "<Figure size 4680x4680 with 1 Axes>"
      ]
     },
     "metadata": {
      "needs_background": "light"
     },
     "output_type": "display_data"
    }
   ],
   "source": [
    "img_dir = '../labtestonline_datasets/dataset_statics/url_item_static_total.png'\n",
    "plt.figure(figsize=(65, 65))\n",
    "img = plt.imread(img_dir)\n",
    "plt.imshow(img)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 21,
   "id": "private-upset",
   "metadata": {},
   "outputs": [],
   "source": [
    "df = pd.read_csv('../labtestonline_datasets/dataset_statics/url_item_static.csv')"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 23,
   "id": "thorough-auditor",
   "metadata": {
    "scrolled": true
   },
   "outputs": [
    {
     "data": {
      "text/plain": [
       "array(['Test Preparation Needed?', 'Why Get Tested?'], dtype=object)"
      ]
     },
     "execution_count": 23,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "a = 'item'\n",
    "df[a].values [:2]"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 5,
   "id": "false-mumbai",
   "metadata": {},
   "outputs": [],
   "source": [
    "questions = df['item'].apply(lambda a: str(a)).values"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 64,
   "id": "monetary-church",
   "metadata": {
    "collapsed": true
   },
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "[nltk_data] Downloading package punkt to\n",
      "[nltk_data]     C:\\Users\\98938\\AppData\\Roaming\\nltk_data...\n",
      "[nltk_data]   Package punkt is already up-to-date!\n",
      "[nltk_data] Downloading package averaged_perceptron_tagger to\n",
      "[nltk_data]     C:\\Users\\98938\\AppData\\Roaming\\nltk_data...\n",
      "[nltk_data]   Package averaged_perceptron_tagger is already up-to-\n",
      "[nltk_data]       date!\n",
      "[nltk_data] Downloading package maxent_ne_chunker to\n",
      "[nltk_data]     C:\\Users\\98938\\AppData\\Roaming\\nltk_data...\n",
      "[nltk_data]   Package maxent_ne_chunker is already up-to-date!\n",
      "[nltk_data] Downloading package words to\n",
      "[nltk_data]     C:\\Users\\98938\\AppData\\Roaming\\nltk_data...\n",
      "[nltk_data]   Package words is already up-to-date!\n"
     ]
    },
    {
     "data": {
      "text/plain": [
       "{('A1c', 'ORGANIZATION'),\n",
       " ('AAT', 'ORGANIZATION'),\n",
       " ('ABO', 'ORGANIZATION'),\n",
       " ('ACT', 'ORGANIZATION'),\n",
       " ('ACTH', 'ORGANIZATION'),\n",
       " ('AChR', 'ORGANIZATION'),\n",
       " ('ADA', 'ORGANIZATION'),\n",
       " ('ADH', 'ORGANIZATION'),\n",
       " ('AEDs', 'ORGANIZATION'),\n",
       " ('AFB', 'ORGANIZATION'),\n",
       " ('AFP', 'ORGANIZATION'),\n",
       " ('ALK', 'ORGANIZATION'),\n",
       " ('ALT', 'ORGANIZATION'),\n",
       " ('AMA', 'ORGANIZATION'),\n",
       " ('AMH', 'ORGANIZATION'),\n",
       " ('ANCA', 'ORGANIZATION'),\n",
       " ('APOE', 'ORGANIZATION'),\n",
       " ('ARR', 'ORGANIZATION'),\n",
       " ('ASCA', 'ORGANIZATION'),\n",
       " ('ASO', 'ORGANIZATION'),\n",
       " ('AST', 'ORGANIZATION'),\n",
       " ('Abuse Epithelial', 'ORGANIZATION'),\n",
       " ('Addison', 'PERSON'),\n",
       " ('Alzheimer', 'ORGANIZATION'),\n",
       " ('Ascorbic Acid', 'PERSON'),\n",
       " ('Average Glucose', 'PERSON'),\n",
       " ('B12', 'PERSON'),\n",
       " ('B2M', 'PERSON'),\n",
       " ('BMP', 'ORGANIZATION'),\n",
       " ('BUN', 'ORGANIZATION'),\n",
       " ('BUN Reference Range Blood', 'ORGANIZATION'),\n",
       " ('Bacteria', 'GPE'),\n",
       " ('Bartter', 'PERSON'),\n",
       " ('Basophils Besides', 'PERSON'),\n",
       " ('Bence Jones', 'PERSON'),\n",
       " ('Besides HCV', 'PERSON'),\n",
       " ('CA', 'ORGANIZATION'),\n",
       " ('CAH', 'ORGANIZATION'),\n",
       " ('CALR', 'ORGANIZATION'),\n",
       " ('CBC', 'ORGANIZATION'),\n",
       " ('CBC Results Can', 'ORGANIZATION'),\n",
       " ('CCP', 'ORGANIZATION'),\n",
       " ('CD4', 'ORGANIZATION'),\n",
       " ('CEA', 'ORGANIZATION'),\n",
       " ('CF', 'ORGANIZATION'),\n",
       " ('CGM', 'ORGANIZATION'),\n",
       " ('CK', 'ORGANIZATION'),\n",
       " ('CMP', 'ORGANIZATION'),\n",
       " ('CMV', 'ORGANIZATION'),\n",
       " ('CRC', 'ORGANIZATION'),\n",
       " ('CRP', 'ORGANIZATION'),\n",
       " ('CSF', 'ORGANIZATION'),\n",
       " ('CSF Chemical Tests Crystals', 'ORGANIZATION'),\n",
       " ('CVD', 'ORGANIZATION'),\n",
       " ('CYP21A2', 'ORGANIZATION'),\n",
       " ('CYP2C19', 'ORGANIZATION'),\n",
       " ('CYP450', 'ORGANIZATION'),\n",
       " ('CgA', 'ORGANIZATION'),\n",
       " ('Chemical Exam Cell Counts', 'PERSON'),\n",
       " ('Choride Reference Range', 'PERSON'),\n",
       " ('Color CO2 Reference Range Chloride Reference Range Can', 'PERSON'),\n",
       " ('DCP', 'ORGANIZATION'),\n",
       " ('DHEAS', 'ORGANIZATION'),\n",
       " ('DNA', 'ORGANIZATION'),\n",
       " ('DRE', 'ORGANIZATION'),\n",
       " ('DVT', 'ORGANIZATION'),\n",
       " ('Differential', 'GPE'),\n",
       " ('Does GBS', 'PERSON'),\n",
       " ('Does NIPS', 'PERSON'),\n",
       " ('Down', 'PERSON'),\n",
       " ('Drugs', 'GPE'),\n",
       " ('EBV', 'ORGANIZATION'),\n",
       " ('EGFR', 'ORGANIZATION'),\n",
       " ('ENA', 'ORGANIZATION'),\n",
       " ('EPO', 'ORGANIZATION'),\n",
       " ('ESR', 'ORGANIZATION'),\n",
       " ('Edwards', 'PERSON'),\n",
       " ('Eosinophils How', 'PERSON'),\n",
       " ('Exam View Sources View', 'PERSON'),\n",
       " ('FDP', 'ORGANIZATION'),\n",
       " ('FIT', 'ORGANIZATION'),\n",
       " ('FOBT', 'ORGANIZATION'),\n",
       " ('FOBTs', 'ORGANIZATION'),\n",
       " ('FSH', 'ORGANIZATION'),\n",
       " ('FTI', 'ORGANIZATION'),\n",
       " ('For Health', 'ORGANIZATION'),\n",
       " ('G6PD', 'ORGANIZATION'),\n",
       " ('GADA', 'ORGANIZATION'),\n",
       " ('GBS', 'ORGANIZATION'),\n",
       " ('GFR', 'ORGANIZATION'),\n",
       " ('GGT', 'ORGANIZATION'),\n",
       " ('GTD', 'ORGANIZATION'),\n",
       " ('GVHD', 'ORGANIZATION'),\n",
       " ('Gabrielle Beninson', 'PERSON'),\n",
       " ('Get', 'PERSON'),\n",
       " ('Gram', 'ORGANIZATION'),\n",
       " ('HBV', 'ORGANIZATION'),\n",
       " ('HCV', 'ORGANIZATION'),\n",
       " ('HDV', 'ORGANIZATION'),\n",
       " ('HE4', 'ORGANIZATION'),\n",
       " ('HER2', 'ORGANIZATION'),\n",
       " ('HES', 'ORGANIZATION'),\n",
       " ('HIT', 'ORGANIZATION'),\n",
       " ('HIV', 'ORGANIZATION'),\n",
       " ('HLA', 'ORGANIZATION'),\n",
       " ('HPV', 'ORGANIZATION'),\n",
       " ('HRT', 'ORGANIZATION'),\n",
       " ('HTLV', 'ORGANIZATION'),\n",
       " ('Hemoglobin', 'ORGANIZATION'),\n",
       " ('Hemoglobin Reference Range Hematocrit Reference Range Glucose', 'PERSON'),\n",
       " ('IAA', 'ORGANIZATION'),\n",
       " ('ICA', 'ORGANIZATION'),\n",
       " ('INR', 'ORGANIZATION'),\n",
       " ('IPF', 'ORGANIZATION'),\n",
       " ('IRF', 'ORGANIZATION'),\n",
       " ('IgE', 'ORGANIZATION'),\n",
       " ('Infections', 'ORGANIZATION'),\n",
       " ('K2', 'PERSON'),\n",
       " ('KRAS', 'ORGANIZATION'),\n",
       " ('LA', 'ORGANIZATION'),\n",
       " ('LD', 'ORGANIZATION'),\n",
       " ('LDL', 'ORGANIZATION'),\n",
       " ('LH', 'ORGANIZATION'),\n",
       " ('Legionella', 'ORGANIZATION'),\n",
       " ('Legionella', 'PERSON'),\n",
       " ('Legionnaires', 'GPE'),\n",
       " ('Lp', 'GPE'),\n",
       " ('MMA', 'ORGANIZATION'),\n",
       " ('MPA', 'ORGANIZATION'),\n",
       " ('MPNs', 'ORGANIZATION'),\n",
       " ('MPV', 'ORGANIZATION'),\n",
       " ('MRSA', 'ORGANIZATION'),\n",
       " ('MTHFR', 'ORGANIZATION'),\n",
       " ('Menkes', 'PERSON'),\n",
       " ('Microscopic Exam', 'PERSON'),\n",
       " ('Microscopic Exam Lymphocytes', 'PERSON'),\n",
       " ('MuSK', 'ORGANIZATION'),\n",
       " ('Myoglobin Blood Creatinine Reference Range Bilirubin Bicarbonate',\n",
       "  'PERSON'),\n",
       " ('NIPS', 'ORGANIZATION'),\n",
       " ('Nitrite Neutrophils My', 'PERSON'),\n",
       " ('OTC', 'ORGANIZATION'),\n",
       " ('PBC', 'ORGANIZATION'),\n",
       " ('PDW', 'ORGANIZATION'),\n",
       " ('PHI', 'ORGANIZATION'),\n",
       " ('PSA', 'ORGANIZATION'),\n",
       " ('PT', 'ORGANIZATION'),\n",
       " ('PTH', 'ORGANIZATION'),\n",
       " ('PTT', 'ORGANIZATION'),\n",
       " ('Philadelphia', 'GSP'),\n",
       " ('Potassium Reference Range', 'PERSON'),\n",
       " ('Prostate Health Index', 'ORGANIZATION'),\n",
       " ('Protein Groups Examples', 'PERSON'),\n",
       " ('RA', 'ORGANIZATION'),\n",
       " ('RBC', 'ORGANIZATION'),\n",
       " ('RBC Count', 'ORGANIZATION'),\n",
       " ('RBCs', 'ORGANIZATION'),\n",
       " ('RDA', 'ORGANIZATION'),\n",
       " ('RPI', 'ORGANIZATION'),\n",
       " ('RSV', 'ORGANIZATION'),\n",
       " ('Range Besides ZPP', 'PERSON'),\n",
       " ('Range How', 'PERSON'),\n",
       " ('Range Red', 'PERSON'),\n",
       " ('Recommended', 'ORGANIZATION'),\n",
       " ('Red Blood Cell Count Reference Range Protein Platelet Tests Platelet Count Reference Range',\n",
       "  'ORGANIZATION'),\n",
       " ('Red Blood Cell Irregularities', 'ORGANIZATION'),\n",
       " ('Rh', 'GPE'),\n",
       " ('RhIg', 'ORGANIZATION'),\n",
       " ('SHBG', 'ORGANIZATION'),\n",
       " ('SMA', 'ORGANIZATION'),\n",
       " ('STD', 'ORGANIZATION'),\n",
       " ('STDs', 'ORGANIZATION'),\n",
       " ('Sample Required', 'PERSON'),\n",
       " ('Shape See Reference Ranges Sample', 'PERSON'),\n",
       " ('Shiga', 'PERSON'),\n",
       " ('Sodium Reference Range', 'PERSON'),\n",
       " ('Sources Size Should', 'PERSON'),\n",
       " ('Sweat Chloride Sample Collection Specific', 'PERSON'),\n",
       " ('TB', 'ORGANIZATION'),\n",
       " ('THC', 'ORGANIZATION'),\n",
       " ('THI', 'ORGANIZATION'),\n",
       " ('TNF', 'ORGANIZATION'),\n",
       " ('TPMT', 'ORGANIZATION'),\n",
       " ('TSH', 'ORGANIZATION'),\n",
       " ('TST', 'ORGANIZATION'),\n",
       " ('Test', 'GPE'),\n",
       " ('Total', 'ORGANIZATION'),\n",
       " ('Trinder', 'PERSON'),\n",
       " ('Tuberculin Skin Test Total Calcium Reference', 'PERSON'),\n",
       " ('U.S.', 'GPE'),\n",
       " ('UTIs', 'ORGANIZATION'),\n",
       " ('Urine', 'PERSON'),\n",
       " ('Urobilinogen Urine', 'PERSON'),\n",
       " ('V Leiden', 'PERSON'),\n",
       " ('V R2', 'PERSON'),\n",
       " ('VLDL', 'ORGANIZATION'),\n",
       " ('VTE', 'ORGANIZATION'),\n",
       " ('VWD', 'ORGANIZATION'),\n",
       " ('VWF', 'ORGANIZATION'),\n",
       " ('Vitamin C', 'PERSON'),\n",
       " ('WBC', 'ORGANIZATION'),\n",
       " ('WBC Differential Reference', 'ORGANIZATION'),\n",
       " ('WBCs', 'ORGANIZATION'),\n",
       " ('WNV', 'ORGANIZATION'),\n",
       " ('West Nile', 'LOCATION'),\n",
       " ('White', 'FACILITY'),\n",
       " ('White Blood Cell', 'FACILITY'),\n",
       " ('White Blood Cell Count Reference Range Who', 'FACILITY'),\n",
       " ('White Blood Cells Details', 'FACILITY'),\n",
       " ('Will', 'PERSON'),\n",
       " ('Will PSA', 'PERSON'),\n",
       " ('Willebrand', 'GPE'),\n",
       " ('ZPP', 'ORGANIZATION'),\n",
       " ('ZnT8A', 'ORGANIZATION'),\n",
       " ('apoB', 'ORGANIZATION'),\n",
       " ('eAG', 'ORGANIZATION'),\n",
       " ('eGFR', 'ORGANIZATION'),\n",
       " ('fFN', 'ORGANIZATION'),\n",
       " ('hCG', 'ORGANIZATION'),\n",
       " ('p2PSA', 'ORGANIZATION'),\n",
       " ('sTfR', 'ORGANIZATION')}"
      ]
     },
     "execution_count": 64,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "import nltk\n",
    "nltk.download('punkt')\n",
    "nltk.download('averaged_perceptron_tagger')\n",
    "nltk.download('maxent_ne_chunker')\n",
    "nltk.download('words')\n",
    "{(' '.join(c[0] for c in chunk), chunk.label() ) for chunk in nltk.ne_chunk(nltk.pos_tag(nltk.word_tokenize('\\n'.join(questions)))) if hasattr(chunk, 'label') }"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 85,
   "id": "metric-convenience",
   "metadata": {},
   "outputs": [],
   "source": [
    "entity_class = ['drag_name', 'test1', 'test2', 'none']"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 35,
   "id": "developing-injection",
   "metadata": {
    "scrolled": true
   },
   "outputs": [
    {
     "data": {
      "text/plain": [
       "[1, 2]"
      ]
     },
     "execution_count": 35,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "a = [1,2,3]\n",
    "a[:-1]"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "id": "multiple-shepherd",
   "metadata": {},
   "outputs": [],
   "source": []
  },
  {
   "cell_type": "code",
   "execution_count": 42,
   "id": "particular-prairie",
   "metadata": {
    "scrolled": true
   },
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Whats these questions intent?\n",
      "Current intent list:  ['yes', 'no', 'maby']\n",
      "Print \"finish\" to finish labeling.\n",
      "Type intent for this question: [ Test Preparation Needed? ]yes\n",
      "Type intent for this question: [ Why Get Tested? ]no\n",
      "Type intent for this question: [ Sample Required? ]finish\n"
     ]
    }
   ],
   "source": [
    "import sys\n",
    "import pandas as pd\n",
    "class LabelQuestions():\n",
    "    def __init__(self, cv_path=None, questions_column_name=None, intent_tag_list=[]):\n",
    "        if cv_path == None:\n",
    "            raise Exception(\"Error: [path] can't be empty.\")\n",
    "        if intent_tag_list==[]:\n",
    "            raise Exception(\"Error: [intent_tag_list] can't be empty\")\n",
    "        if questions_column_name==None:\n",
    "            raise Exception(\"Error: [questions_column_name] can't be empty\")\n",
    "            \n",
    "        self.path = cv_path\n",
    "        self.tag_list = intent_tag_list\n",
    "        self.questions = pd.read_csv(self.path)[questions_column_name].values\n",
    "        self.intents = []\n",
    "    def run(self, saved_name=None):\n",
    "        print('Whats these questions intent?')\n",
    "        print('Current intent list: ' , self.tag_list)\n",
    "        print('Print \"finish\" to finish labeling.')\n",
    "        counter = 0\n",
    "        for q in self.questions:\n",
    "            intent = ''\n",
    "            while(not intent in self.tag_list):\n",
    "                intent = input('Type intent for this question: [ '+q+' ]')\n",
    "                if intent=='finish':\n",
    "                    self.finishing(counter, saved_name)\n",
    "                    return\n",
    "                if intent in self.tag_list:\n",
    "                    self.intents.append(intent)\n",
    "                    break\n",
    "                else :\n",
    "                    print('ERROR: I done have this tag in our list type one of current intent list.')\n",
    "            counter += 1\n",
    "        print(self.intents)\n",
    "        \n",
    "    def finishing(self, counter, saved_name):\n",
    "        self.df = pd.DataFrame(list(zip(self.questions[:counter],self.intents)), columns=['question', 'intent'])\n",
    "        if saved_name:\n",
    "            self.df.to_csv('/'.join(self.path.split('/')[:-1])+'/'+saved_name, index=False)\n",
    "def main():\n",
    "    args = sys.argv\n",
    "    intent_tag_list = ['usage_lab','detail_lab','need_lab','during_lab','prepare_lab','risk_lab','result_lab','any_detail_lab']\n",
    "    LabelQuestions(cv_path=args[1], questions_column_name=args[2], intent_tag_list=intent_tag_list).run(args[3])  \n",
    "if __name__ == '__main__':\n",
    "    main()\n"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 41,
   "id": "solved-mountain",
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Untitled.ipynb\n"
     ]
    }
   ],
   "source": [
    "!ls"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "id": "according-sarah",
   "metadata": {},
   "outputs": [],
   "source": [
    "print('Entity list: ', str(entity_class))\n",
    "for q in questions[:1]:\n",
    "    print(str(q))\n",
    "    for word in q.split(' '):\n",
    "        print(\"Whats this word entity: %s \" % word)\n",
    "        w_entity = input()"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 4,
   "id": "angry-nightmare",
   "metadata": {},
   "outputs": [],
   "source": [
    "nlp = spacy.load('en_core_web_sm')"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 10,
   "id": "arctic-vietnam",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "'Test Preparation Needed? Why Get Tested? Sample Required? What is being tested? When To Get Tested? When is it ordered? What does the test result mean? Is there anything else I should know? How is the test used? How is it used? How is the sample collected for testing? Is any test preparation needed to ensure the quality of the sample? Health Professionals  LOINC See Reference Range How long will it take for results? How long will it take for my results? How long will it take for my results? How long does it take to get results? What other lab tests may be done? What is a direct LDL cholesterol test?'"
      ]
     },
     "execution_count": 10,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "text = ' '.join(questions[:20])\n",
    "text"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 11,
   "id": "attached-peripheral",
   "metadata": {},
   "outputs": [],
   "source": [
    "doc = nlp(' '.join(questions))"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 7,
   "id": "juvenile-child",
   "metadata": {},
   "outputs": [],
   "source": [
    "from spacy import displacy"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 12,
   "id": "baking-needle",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/html": [
       "<span class=\"tex2jax_ignore\"><!DOCTYPE html>\n",
       "<html lang=\"en\">\n",
       "    <head>\n",
       "        <title>displaCy</title>\n",
       "    </head>\n",
       "\n",
       "    <body style=\"font-size: 16px; font-family: -apple-system, BlinkMacSystemFont, 'Segoe UI', Helvetica, Arial, sans-serif, 'Apple Color Emoji', 'Segoe UI Emoji', 'Segoe UI Symbol'; padding: 4rem 2rem; direction: ltr\">\n",
       "<figure style=\"margin-bottom: 6rem\">\n",
       "<div class=\"entities\" style=\"line-height: 2.5; direction: ltr\">Test Preparation Needed? Why Get Tested? Sample Required? What is being tested? When To Get Tested? When is it ordered? What does the test result mean? Is there anything else I should know? How is the test used? How is it used? How is the sample collected for testing? Is any test preparation needed to ensure the quality of the sample? \n",
       "<mark class=\"entity\" style=\"background: #aa9cfc; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    Health Professionals \n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">PERSON</span>\n",
       "</mark>\n",
       " LOINC See Reference Range How long will it take for results? How long will it take for my results? How long will it take for my results? How long does it take to get results? What other lab tests may be done? What is a direct LDL cholesterol test? What is a direct LDL cholesterol test? How long does it take for results? Overview When to Get Tested? How long will it take to get the results of my test? How long will it take to get the results of my test? Where can I get tested? Should everyone with leukemia be tested? Why do I have to collect my urine for \n",
       "<mark class=\"entity\" style=\"background: #bfe1d9; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    24 hours\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">TIME</span>\n",
       "</mark>\n",
       "? Can I have decreased or abnormal fibrinogen and not know it? Can results of testing be used to determine the course of my cancer? Can results of testing be used to determine the course of my cancer? Can I have more than one cause of hepatitis? Why would a man need a test for \n",
       "<mark class=\"entity\" style=\"background: #7aecec; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    FSH\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">ORG</span>\n",
       "</mark>\n",
       " and \n",
       "<mark class=\"entity\" style=\"background: #aa9cfc; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    LH\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">PERSON</span>\n",
       "</mark>\n",
       "? I thought these were female hormones. Can this test be done in my healthcare practitioner's office? When are they ordered? Are these tests always run as a panel? If I have \n",
       "<mark class=\"entity\" style=\"background: #7aecec; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    CAH\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">ORG</span>\n",
       "</mark>\n",
       ", or my child does, should my family members be tested? Who needs iron supplements? If I have \n",
       "<mark class=\"entity\" style=\"background: #7aecec; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    CAH\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">ORG</span>\n",
       "</mark>\n",
       ", or my child does, should my family members be tested? What is \n",
       "<mark class=\"entity\" style=\"background: #aa9cfc; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    Menkes\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">PERSON</span>\n",
       "</mark>\n",
       " kinky hair syndrome? \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    Potassium Reference Range\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">FAC</span>\n",
       "</mark>\n",
       " What is the difference between serum/plasma albumin, prealbumin, and urine albumin tests? Can I choose either a blood or a urine B2M test? Can I get antibodies from donating blood? How fast does autoimmune hepatitis progress? How is anaphylaxis treated? Can I have \n",
       "<mark class=\"entity\" style=\"background: #e4e7d2; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    more than one\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CARDINAL</span>\n",
       "</mark>\n",
       " pheochromocytoma at once? What medications can affect thyroid testing? How can my actual GFR be determined? Do healthcare practitioners test thyroid hormones during pregnancy? Would this testing also be performed on a man? What other testing might be done? What causes pancreatic insufficiency? Will my results be accurate if I must continue to take my medication? Are some people at a higher risk for developing a carcinoid tumor? Can this test be performed by my local laboratory? Should everyone have their \n",
       "<mark class=\"entity\" style=\"background: #7aecec; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    APOE\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">ORG</span>\n",
       "</mark>\n",
       " genotype tested? Can this test be performed by my local laboratory? How serious is myasthenia gravis (\n",
       "<mark class=\"entity\" style=\"background: #7aecec; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    MG\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">ORG</span>\n",
       "</mark>\n",
       ")? How serious is myasthenia gravis (\n",
       "<mark class=\"entity\" style=\"background: #7aecec; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    MG\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">ORG</span>\n",
       "</mark>\n",
       ")? Is it really necessary to collect urine for \n",
       "<mark class=\"entity\" style=\"background: #bfe1d9; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    24 hours\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">TIME</span>\n",
       "</mark>\n",
       "? Can \n",
       "<mark class=\"entity\" style=\"background: #aa9cfc; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    MG\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">PERSON</span>\n",
       "</mark>\n",
       " be inherited? Do I need to have a liver biopsy? Can I have my blood tested instead of having a tissue biopsy? Can \n",
       "<mark class=\"entity\" style=\"background: #aa9cfc; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    MG\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">PERSON</span>\n",
       "</mark>\n",
       " be inherited? Are there other genetic mutations associated with MPNs? What is rhabdomyolysis? What is \n",
       "<mark class=\"entity\" style=\"background: #aa9cfc; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    Edwards\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">PERSON</span>\n",
       "</mark>\n",
       " syndrome? Why would my healthcare provider order additional tests? If I have chest pain, does that mean I am having a heart attack? What else can cause diarrhea? If I have chest pain, does that mean I am having a heart attack? Is there a reason to test for \n",
       "<mark class=\"entity\" style=\"background: #7aecec; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    APOE\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">ORG</span>\n",
       "</mark>\n",
       " genotype more than once? Sodium Reference Range What is \n",
       "<mark class=\"entity\" style=\"background: #aa9cfc; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    Down\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">PERSON</span>\n",
       "</mark>\n",
       " syndrome? What is rhabdomyolysis? Can this test be performed on my blood instead? Can this test be performed on my blood instead? Are there other non-invasive screening tests for these disorders? Should I tell my partner that I have syphilis? Should I tell my partner that I have chlamydia? Should I tell my other healthcare providers that I am taking sirolimus? Should I tell my other healthcare providers about my \n",
       "<mark class=\"entity\" style=\"background: #e4e7d2; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    CYP2C19\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CARDINAL</span>\n",
       "</mark>\n",
       " test results? Should I tell my other doctors I have \n",
       "<mark class=\"entity\" style=\"background: #aa9cfc; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    von Willebrand\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">PERSON</span>\n",
       "</mark>\n",
       " disease? Should I tell other doctors about my warfarin sensitivity? Should I tell my partner that I have trichomoniasis? Should I tell my other healthcare providers that I am taking tacrolimus? Should I tell my other healthcare providers that I am taking mycophenolate? nan Should I tell my healthcare providers that I am taking clopidogrel? Should I get a tuberculosis screening test if I am pregnant? Should everyone with liver damage be tested for liver kidney microsome type \n",
       "<mark class=\"entity\" style=\"background: #e4e7d2; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    1\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CARDINAL</span>\n",
       "</mark>\n",
       " antibodies (anti-LKM-1)? Should everyone with lung cancer have \n",
       "<mark class=\"entity\" style=\"background: #7aecec; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    ALK\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">ORG</span>\n",
       "</mark>\n",
       " mutation testing? Should everyone with muscle pain and weakness have a \n",
       "<mark class=\"entity\" style=\"background: #7aecec; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    CK\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">ORG</span>\n",
       "</mark>\n",
       " test? Should everyone with muscle pain and weakness have a myoglobin test? Should everyone with suspected tuberculosis have an \n",
       "<mark class=\"entity\" style=\"background: #7aecec; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    ADA\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">ORG</span>\n",
       "</mark>\n",
       " test performed? Should every pregnant woman have a folate test? Should every pregnant woman have amniotic fluid analysis? Should every woman be treated with antibiotics for \n",
       "<mark class=\"entity\" style=\"background: #7aecec; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    GBS\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">ORG</span>\n",
       "</mark>\n",
       " during delivery or during pregnancy? Should I ask my healthcare practitioner about having \n",
       "<mark class=\"entity\" style=\"background: #7aecec; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    NIPS\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">ORG</span>\n",
       "</mark>\n",
       " performed? Should I be concerned if my doctor only orders a total calcium test and not free or ionized calcium? Should I be taking copper supplements or trying to get more copper in my diet? Should I be tested for HTLV-I/II if I have some of the risk factors? Should I eat more protein to make up for lost protein? Should I get a flu shot? Should I get a tuberculosis skin test if I am pregnant? Should I tell my dentist or other healthcare providers about my antithrombin deficiency? Should I get the \n",
       "<mark class=\"entity\" style=\"background: #7aecec; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    HBV\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">ORG</span>\n",
       "</mark>\n",
       " vaccine? Should I have a PT done at the same time of day? Should I have a test for CA \n",
       "<mark class=\"entity\" style=\"background: #e4e7d2; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    27.29\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CARDINAL</span>\n",
       "</mark>\n",
       " in addition to the CA 15-3 test? Should I have both the serotonin and \n",
       "<mark class=\"entity\" style=\"background: #e4e7d2; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    5\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CARDINAL</span>\n",
       "</mark>\n",
       "-HIAA tests performed? Should my other family members be tested for warfarin sensitivity? Should I take magnesium supplements? And if so, how much? Should I take mineral supplements? Should I tell all my healthcare providers about being diagnosed with drug-induced lupus? Should I tell all of my doctors if I have \n",
       "<mark class=\"entity\" style=\"background: #7aecec; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    CAH\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">ORG</span>\n",
       "</mark>\n",
       "? Should I tell all of my doctors that I am taking theophylline? Should I tell all of my healthcare practitioners if I have \n",
       "<mark class=\"entity\" style=\"background: #7aecec; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    CAH\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">ORG</span>\n",
       "</mark>\n",
       "? Should I tell all of my healthcare practitioners that I have an HIT antibody? Should I tell a new healthcare practitioner that I have antiphospholipid antibodies? Should I tell a new healthcare provider that I have cardiolipin antibodies? Should I just take iron supplements? Tests for Infections Shouldn't someone with a family history of diabetes have a fructosamine test? What are the risk factors for preterm labor and delivery? What are the recommended dietary allowances (\n",
       "<mark class=\"entity\" style=\"background: #7aecec; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    RDA\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">ORG</span>\n",
       "</mark>\n",
       ") for vitamin A? What are \n",
       "<mark class=\"entity\" style=\"background: #7aecec; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    the Recommended Dietary Allowances\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">ORG</span>\n",
       "</mark>\n",
       " (RDA) for B vitamins? What are the recommendations for rubella vaccination? What are the reasons to test for a specific HLA gene allele? What are the pros and cons of the TPMT phenotype test and the genotype test? What are the other parts of the innate immune system? What are the main risk factors for pancreatic cancer? What are the long-term consequences of pancreatitis? What are the dietary sources of vitamin A? What are the causes of primary adrenal insufficiency? What are symptoms of low magnesium? What are some types of lab methods used for this testing? What are some traditional tests for respiratory infections? What are some tests that may be done to help decide whether a prostate cancer is likely to be fast-growing and spread (metastasize) and therefore should be removed rather than watched? What are some tests that may be done in follow up? What are some side effects of immunotherapy? What are some serious side effects of levetiracetam? What are the risk factors for liver cancer? What are the treatment options for bacterial infections? Should pregnant women be vaccinated for rubella? What are the usual treatments for diabetes? What can I do to make my creatinine level normal? What can I do to lower or increase leptin levels? What can I do to lower my \n",
       "<mark class=\"entity\" style=\"background: #7aecec; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    CRP\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">ORG</span>\n",
       "</mark>\n",
       " level? What can I do to lower my apo B? What can I do to increase or decrease bone marker results? What can I do to help prevent formation of a neural tube defect? What can I do to decrease my lactoferrin? What can I do to decrease my calprotectin? What can I do to change my histone antibody level? What can I do to avoid the symptoms of cold agglutinin disease? What can I do to avoid getting a bacterial infection of the digestive tract? What can cause false-positive results in a marijuana test? What can cause a false-positive result? What can cause a false-negative urine hCG? What can be done about post-lumbar puncture pain? What are tumor markers? What are total testosterone, free testosterone, and bioavailable testosterone? What are some other tests that might be done to detect iron deficiency or iron overload? What are some other tests that may be done when the \n",
       "<mark class=\"entity\" style=\"background: #7aecec; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    PSA\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">ORG</span>\n",
       "</mark>\n",
       " level is only slightly elevated to help decide whether a prostate cancer is present? What are some other tests that may be done to determine the underlying cause of cryoglobulinemia? What are some other risk factors for ovarian cancer? \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    Visual Exam View Sources View Comprehensive Table of Drugs\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">FAC</span>\n",
       "</mark>\n",
       " that May Be Tested Urobilinogen Urine color Urine clarity Tuberculin Skin Test Total Calcium Reference Range The size of the swelling is measured and used to determine if the \n",
       "<mark class=\"entity\" style=\"background: #7aecec; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    TB\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">ORG</span>\n",
       "</mark>\n",
       " skin test is positive or negative. Image credit: \n",
       "<mark class=\"entity\" style=\"background: #aa9cfc; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    Gabrielle Beninson\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">PERSON</span>\n",
       "</mark>\n",
       ", \n",
       "<mark class=\"entity\" style=\"background: #7aecec; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    CDC\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">ORG</span>\n",
       "</mark>\n",
       " The results of my hepatitis panel came back negative.  What other conditions can cause similar symptoms? The names \n",
       "<mark class=\"entity\" style=\"background: #7aecec; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    HTLV\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">ORG</span>\n",
       "</mark>\n",
       " and HIV look and sound similar  are these diseases related? Sweat Chloride Sample Collection Specific gravity Sources Size Should someone with a factor V \n",
       "<mark class=\"entity\" style=\"background: #aa9cfc; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    Leiden\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">PERSON</span>\n",
       "</mark>\n",
       " mutation be on long-term anticoagulant therapy? Should relatives of someone with an inherited protein C or protein S deficiency be tested? WBC Differential Reference Range What are aldosterone stimulation and suppression tests? What are appropriate treatments for the common causes of low potassium (hypokalemia) and high potassium (hyperkalemia)? What are some causes of anemia besides iron deficiency? What are some other details about T cells? What are some other details about B cells? What are some of the specific methods used to analyze kidney stones? What are some good sources of folic acid and vitamins \n",
       "<mark class=\"entity\" style=\"background: #aa9cfc; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    B6\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">PERSON</span>\n",
       "</mark>\n",
       " and \n",
       "<mark class=\"entity\" style=\"background: #7aecec; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    B12\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">ORG</span>\n",
       "</mark>\n",
       "? What are some good dietary sources of potassium? What are some common risk factors for inappropriate blood clotting? What are some common opportunistic infections I might get if I have an HIV infection? What are some additional details on \n",
       "<mark class=\"entity\" style=\"background: #feca74; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    LA\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">GPE</span>\n",
       "</mark>\n",
       " testing results? What are \n",
       "<mark class=\"entity\" style=\"background: #aa9cfc; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    Bence Jones\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">PERSON</span>\n",
       "</mark>\n",
       " proteins? What are phytoestrogens and environmental estrogens? What are my treatment options? What are globulin proteins and how are they measured in blood? What are free light chains and how are they related to immunoglobulins? What are estrogen receptors? What are congenital (inherited) dysfibrinogenemia, hypofibrinogenemia and afibrinogenemia? What are chronic inflammatory diseases? Should everyone with flu-like symptoms be tested for \n",
       "<mark class=\"entity\" style=\"background: #aa9cfc; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    Legionella\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">PERSON</span>\n",
       "</mark>\n",
       "? Should everyone have an Lp-PLA2 test? Should everyone with cancer have \n",
       "<mark class=\"entity\" style=\"background: #7aecec; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    KRAS\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">ORG</span>\n",
       "</mark>\n",
       " mutation testing? \n",
       "<mark class=\"entity\" style=\"background: #aa9cfc; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    Leukocyte\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">PERSON</span>\n",
       "</mark>\n",
       " esterase I will have several thyroglobulin tests done over time. Why do I need to have them done at the same lab? I was diagnosed with ductal-carcinoma in situ. Will hormone receptor testing be done? Ive recently been diagnosed with type \n",
       "<mark class=\"entity\" style=\"background: #e4e7d2; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    2\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CARDINAL</span>\n",
       "</mark>\n",
       " diabetes. Will I need to monitor my glucose levels every day? Ive heard some athletes are tested for EPO. Why? Ive heard of &quot;ultrasensitive \n",
       "<mark class=\"entity\" style=\"background: #7aecec; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    PSA\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">ORG</span>\n",
       "</mark>\n",
       ".&quot; What is it? Ive heard of Trinder's test for salicylates. What is it? Ive heard of a stool DNA test for colon cancer screening. What is it? I've had strep throat before and was treated with antibiotics. Can I get it again? I've had pneumonia before and currently have asthma. Why has my doctor never ordered this test for me? Is vitamin D a necessary component of calcium supplements? Is toxoplasmosis treatable? Is toxoplasmosis contagious? Is this the same parvovirus that affects dogs and cats? Can I catch it from my pet? Is this test used for purposes other than detecting problems with the adrenal gland, ovaries or testicles? Is this test used for other purposes? Is this test recommended for everyone with cancer? Is this test different than a platelet function test? Ketones Like a flu test or strep test, can this test be performed in my healthcare practitioner's office? Is there treatment for \n",
       "<mark class=\"entity\" style=\"background: #7aecec; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    VWD\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">ORG</span>\n",
       "</mark>\n",
       "? Like the rapid strep test, can the anti-DNase B test be performed in my doctor's office? My doctor ordered a stool osmolality test. Why? My doctor instructed me to take my iron supplement and then have an iron test done.  Why would that be? My creatinine result is slightly out of range. What does this mean? My complete blood count (CBC) report includes a result for reticulocyte hemoglobin. What is it? My complete blood count (CBC) report includes a result for immature platelet fraction (\n",
       "<mark class=\"entity\" style=\"background: #7aecec; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    IPF\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">ORG</span>\n",
       "</mark>\n",
       "). What is it? My complete blood count (CBC) report includes a result for immature granulocytes (\n",
       "<mark class=\"entity\" style=\"background: #7aecec; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    IG\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">ORG</span>\n",
       "</mark>\n",
       "). What are they? My chloride level is only slightly out of range. What does this mean? My \n",
       "<mark class=\"entity\" style=\"background: #7aecec; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    CBC\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">ORG</span>\n",
       "</mark>\n",
       " report includes a result for reticulocyte hemoglobin. What is it? My \n",
       "<mark class=\"entity\" style=\"background: #7aecec; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    CBC\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">ORG</span>\n",
       "</mark>\n",
       " report includes a result for immature platelet fraction (\n",
       "<mark class=\"entity\" style=\"background: #7aecec; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    IPF\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">ORG</span>\n",
       "</mark>\n",
       "). What is it? My \n",
       "<mark class=\"entity\" style=\"background: #7aecec; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    CBC\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">ORG</span>\n",
       "</mark>\n",
       " report includes a result for immature granulocytes (\n",
       "<mark class=\"entity\" style=\"background: #7aecec; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    IG\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">ORG</span>\n",
       "</mark>\n",
       "). What are they? My \n",
       "<mark class=\"entity\" style=\"background: #7aecec; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    BUN\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">ORG</span>\n",
       "</mark>\n",
       " result is slightly out of range. What does this mean? My bicarbonate level is only slightly out of range. What does this mean? My allergy test was negative, but I continue to have symptoms. What else could it be? My allergy symptoms are generally mild. How serious is this really? Monocytes Microscopic Exam Lymphocytes Is the time of day a factor when collecting a urine sample? Is there treatment available for lactose intolerance? My doctor ordered more blood cultures after the initial cultures were drawn. Why? Is there anything I can do to prevent getting \n",
       "<mark class=\"entity\" style=\"background: #aa9cfc; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    AChR\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">PERSON</span>\n",
       "</mark>\n",
       " binding antibodies? Is there anything I can do to lower my \n",
       "<mark class=\"entity\" style=\"background: #7aecec; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    LD\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">ORG</span>\n",
       "</mark>\n",
       "? Is there anything I can do to lower my IgE level? Is there anything I can do to lower my \n",
       "<mark class=\"entity\" style=\"background: #7aecec; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    CK\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">ORG</span>\n",
       "</mark>\n",
       " level? Is there anything I can do to increase protein C and protein S levels? Is there anything I can do to get rid of the alcohol in my system faster? Is there anything I can do to get rid of lupus anticoagulant? Is there anything I can do to decrease my lactate level? Is there anything I can do to decrease my anticentromere antibody level? Is there anything I can do to affect my anti-dsDNA level? Is there any reason to repeat a &lt;em&gt;JAK2&lt;/em&gt; mutation test? Is there any other way to measure my oxygen levels? Is there a home test I can use to check my potassium level? Is there a home test for \n",
       "<mark class=\"entity\" style=\"background: #aa9cfc; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    LH\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">PERSON</span>\n",
       "</mark>\n",
       "? Is there a home test for hemoglobin A1c? Is there a home test for \n",
       "<mark class=\"entity\" style=\"background: #7aecec; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    FSH\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">ORG</span>\n",
       "</mark>\n",
       "? Is there a home test for \n",
       "<mark class=\"entity\" style=\"background: #7aecec; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    albumin levels\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">ORG</span>\n",
       "</mark>\n",
       "? Is there a blood test for \n",
       "<mark class=\"entity\" style=\"background: #7aecec; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    RSV\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">ORG</span>\n",
       "</mark>\n",
       "? Is there anything I can do to prevent albuminuria (microalbuminuria)? Is there anything I can do to prevent getting \n",
       "<mark class=\"entity\" style=\"background: #bfeeb7; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    MuSK\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">PRODUCT</span>\n",
       "</mark>\n",
       " binding antibodies? Is there something I can do to get rid of my cryoglobulins? Is there anything I can do to prevent or get rid of antiphospholipid antibodies? Is there something I can do to alter my immunoglobulin levels? Is there a way to prevent viral hepatitis? Is there a way to prevent hepatitis A? Is there a way to naturally increase my testosterone? Is there a vaccine like the flu shot to prevent \n",
       "<mark class=\"entity\" style=\"background: #7aecec; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    RSV\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">ORG</span>\n",
       "</mark>\n",
       "? Is there a vaccine for \n",
       "<mark class=\"entity\" style=\"background: #ff9561; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    West Nile\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">LOC</span>\n",
       "</mark>\n",
       " virus (\n",
       "<mark class=\"entity\" style=\"background: #7aecec; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    WNV\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">ORG</span>\n",
       "</mark>\n",
       ")? Is there a urine test for bilirubin? Is there a treatment for low EPO? Is there a reason to test a &quot;peak&quot; sample when my TNF inhibitor should be at its highest level, or a random sample (neither peak nor trough)? Is there a reason to repeat a xylose test? Is there a reason to choose \n",
       "<mark class=\"entity\" style=\"background: #e4e7d2; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    one\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CARDINAL</span>\n",
       "</mark>\n",
       " type of sample (blood, bone marrow, or tissue) over another for testing? Is there any way to prevent getting \n",
       "<mark class=\"entity\" style=\"background: #7aecec; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    CMV\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">ORG</span>\n",
       "</mark>\n",
       "? Is there any way to prevent getting a parvovirus \n",
       "<mark class=\"entity\" style=\"background: #7aecec; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    B19\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">ORG</span>\n",
       "</mark>\n",
       " infection? Is there any way to prevent a pheochromocytoma from forming? Is there any way to lower my Lp(a)? Is there any way to cure iron overload? Is there anything I can do to raise or lower my thyroglobulin level? My doctor ordered a test for albumin-corrected calcium. What is it? My doctor ordered only a \n",
       "<mark class=\"entity\" style=\"background: #e4e7d2; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    4\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CARDINAL</span>\n",
       "</mark>\n",
       "-test ENA panel, not a \n",
       "<mark class=\"entity\" style=\"background: #e4e7d2; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    6\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CARDINAL</span>\n",
       "</mark>\n",
       "-test ENA panel.  Will something be missed? Should everyone who takes aspirin regularly have a salicylate test performed? Should everyone be tested for &lt;em&gt;H. pylori&lt;/em&gt;? Should everyone be tested for \n",
       "<mark class=\"entity\" style=\"background: #7aecec; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    CCP\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">ORG</span>\n",
       "</mark>\n",
       " antibody? Should everyone be tested for arboviruses? Should everyone be tested for antiphospholipid antibodies? Should both a lactoferrin and a calprotectin test be done? Should athletes and others pay particular attention to re-hydrating after playing sports or exercising to keep their sodium levels up? Should all antibiotic therapy be monitored like aminoglycosides? \n",
       "<mark class=\"entity\" style=\"background: #aa9cfc; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    Shape See Reference Ranges Sample\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">PERSON</span>\n",
       "</mark>\n",
       " required? \n",
       "<mark class=\"entity\" style=\"background: #aa9cfc; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    Reticulocyte Count Reference Range Red\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">PERSON</span>\n",
       "</mark>\n",
       " blood cells (RBCs) Red Blood Cell (RBC) Tests Red Blood Cell Count Reference Range Protein Platelet Tests Platelet Count Reference Range pH Should everyone be tested for \n",
       "<mark class=\"entity\" style=\"background: #e4e7d2; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    CYP2C19\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CARDINAL</span>\n",
       "</mark>\n",
       " gene variations? Should everyone be tested for HTLV-I/II? Other than stool tests, are there other ways of screening for colon cancer? Should everyone be tested for measles and mumps immunity? Should everyone who is overweight have a leptin test performed? Should everyone have vitamin B12 and folate tests? Should everyone have this testing done? Should everyone have their levels of trace minerals tested? Should everyone have their B vitamin levels checked? Should everyone have platelet function tests? Should everyone have lactose tolerance testing? Should everyone have bone marker testing performed? Should everyone have a ZPP test? Should everyone have a serum free light chain test? Should everyone have a parietal cell antibody test? Should everyone have an \n",
       "<mark class=\"entity\" style=\"background: #7aecec; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    RBC\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">ORG</span>\n",
       "</mark>\n",
       " antibody screen performed? What can I do to prevent the spread of strep throat? Should everyone have an Lp(a) test done? Should everyone have an intrinsic factor antibody test? Should everyone have an HLA-B27 test done? Should everyone be tested for toxoplasmosis? Other than stool tests, are there other ways to screen for colon cancer? Other than organ and tissue compatibility testing, what else is HLA gene and antigen testing used for? My doctor said I have &lt;em&gt;Bordetella parapertussis&lt;/em&gt;. Is this the same as whooping cough? My \n",
       "<mark class=\"entity\" style=\"background: #7aecec; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    RBC\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">ORG</span>\n",
       "</mark>\n",
       " count is slightly out of range. What does this mean? My potassium level is only slightly out of range. What does this mean? My platelet count is low. How can I increase it? My newborn had a \n",
       "<mark class=\"entity\" style=\"background: #7aecec; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    TSH\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">ORG</span>\n",
       "</mark>\n",
       " test done. Why? My newborn had an MMA test done. Why? My newborn had an immunoglobulin test. Why? My newborn had a homocysteine test done. Why? My newborn had a free \n",
       "<mark class=\"entity\" style=\"background: #7aecec; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    T4\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">ORG</span>\n",
       "</mark>\n",
       " test. Why? My mother was diagnosed as having porphyria \n",
       "<mark class=\"entity\" style=\"background: #bfe1d9; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    many years ago\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DATE</span>\n",
       "</mark>\n",
       " but has not had any symptoms since then. Why is this? My lab report includes a cholesterol ratio. What is it? My iron level is normal, but my ferritin level is low. Why is that? My healthcare practitioner's office called to say they need a new urine sample, the \n",
       "<mark class=\"entity\" style=\"background: #e4e7d2; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    first\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">ORDINAL</span>\n",
       "</mark>\n",
       " was contaminated. What happened? My \n",
       "<mark class=\"entity\" style=\"background: #7aecec; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    healthcare\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">ORG</span>\n",
       "</mark>\n",
       " practitioner says my viral load is too low for drug resistance testing. Why? My healthcare practitioner said I had symptoms of a urinary tract infection and prescribed antibiotics without performing a urine culture. Why? My healthcare practitioner ordered a test for thiopurine metabolites. What is it and how is it related to TPMT testing? My father has been diagnosed with probable late onset Alzheimer disease and his \n",
       "<mark class=\"entity\" style=\"background: #7aecec; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    APOE\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">ORG</span>\n",
       "</mark>\n",
       " genotype test is negative for \n",
       "<mark class=\"entity\" style=\"background: #bfeeb7; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    e4\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">PRODUCT</span>\n",
       "</mark>\n",
       " alleles. Should his doctor be doing other genetic testing? My father has been diagnosed with early onset Alzheimer disease. Can my doctor tell if my father has a genetic mutation without a blood test? My doctor told me that my extra ACTH is not produced in my pituitary gland. What is going on? My PT/INR results vary sometimes, yet my doctor doesnt change my prescription. Why? My report includes an M/E ratio. What is it? \n",
       "<mark class=\"entity\" style=\"background: #e4e7d2; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    One\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CARDINAL</span>\n",
       "</mark>\n",
       " of the results from my renal panel is slightly out of range. What does this mean? My report includes mean platelet volume (\n",
       "<mark class=\"entity\" style=\"background: #7aecec; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    MPV\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">ORG</span>\n",
       "</mark>\n",
       ") and platelet distribution width (\n",
       "<mark class=\"entity\" style=\"background: #7aecec; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    PDW\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">ORG</span>\n",
       "</mark>\n",
       "). What are they? \n",
       "<mark class=\"entity\" style=\"background: #e4e7d2; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    One\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CARDINAL</span>\n",
       "</mark>\n",
       " of the results from my electrolyte panel is slightly out of range. What does this mean? \n",
       "<mark class=\"entity\" style=\"background: #e4e7d2; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    One\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CARDINAL</span>\n",
       "</mark>\n",
       " of the results from my \n",
       "<mark class=\"entity\" style=\"background: #bfeeb7; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    BMP\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">PRODUCT</span>\n",
       "</mark>\n",
       " is slightly out of range. What does this mean? Once I've had a pathogenic bacterial infection, can I be re-infected? Once I've had a parasitic infection, can I be re-infected? Once I've had a &lt;em&gt;C. difficile&lt;/em&gt; infection, can I be re-infected? Once I have had a &lt;em&gt;Toxoplasma gondii&lt;/em&gt; infection, can I get infected again? Once I have gestational diabetes, will I continue to have diabetes after delivery? Once I have developed TNF inhibitor antibodies, will they go away? Once I have been treated for a bacterial lower respiratory tract infection, can the infection return? Once I have been treated, can my infection return? Once I have been treated and/or recovered from hepatitis C, can I get infected again? Nitrite Neutrophils My uric acid level is high, but I don't have gout. What does this mean? My sodium level is only slightly out of range. What does this mean? My report mentions &quot;giant platelets.&quot; What are they? My report mentions a &quot;left shift.&quot; What does this mean? What can I do to prevent a kidney stone and prevent recurrence? What does the test result mean (adults)? What can I do to protect against arboviruses? Who orders lithium tests? Why does my doctor want me to go to the same laboratory each time I have my HIV viral load tested? Why does it need to be a fresh stool sample? Why does insulin have to be injected? Why didn't my healthcare practitioner check my thyroglobulin level before removing my thyroid? Why did my doctor report my child's whooping cough? Why did I get sick eating something when I travelled internationally, but the locals who ate the same thing did not get sick? Why can blood culture results take so long? Why are some inherited bleeding disorders more severe than others? Why aren't antibiotics a recommended treatment for an infection with Shiga toxin-producing E. coli ? Why are my A1c and blood glucose different? Why are factors such as age, sex, and race used in eGFR calculations? Why are aminoglycosides used at all if they can cause permanent hearing loss? Who should take iron supplements? Who performs MTHFR testing? Who performs arbovirus testing? Who performs a kidney stone analysis? Who orders tacrolimus tests? Why does my doctor want to know all of the medications and supplements I am taking? Why does my doctor want to send a \n",
       "<mark class=\"entity\" style=\"background: #e4e7d2; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    second\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">ORDINAL</span>\n",
       "</mark>\n",
       " sTfR test to the same laboratory as the \n",
       "<mark class=\"entity\" style=\"background: #e4e7d2; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    first\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">ORDINAL</span>\n",
       "</mark>\n",
       " test? Why does my lab report also list carboxyhemoglobin? What is it? Why is having syphilis a problem during pregnancy? Why is my healthcare provider testing me for \n",
       "<mark class=\"entity\" style=\"background: #e4e7d2; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    21\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CARDINAL</span>\n",
       "</mark>\n",
       "-hydroxylase autoantibodies and/or adrenal cytoplasmic autoantibodies? Why is my healthcare provider asking me to take my \n",
       "<mark class=\"entity\" style=\"background: #7aecec; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    TB\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">ORG</span>\n",
       "</mark>\n",
       " medication in the presence of a nurse? Why is my healthcare practitioner not screening me for CA 19-9? Why is my family history important? Why is mono sometimes called &quot;the kissing disease&quot;? Why is it important to have my blood drawn for my digoxin test at a certain time? Why is it called \n",
       "<mark class=\"entity\" style=\"background: #aa9cfc; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    Legionnaires\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">PERSON</span>\n",
       "</mark>\n",
       " disease? Why is every newborn screened for hemoglobinopathies? Why doesn't a drug screen measure all drugs? Why haven't I heard about mycoplasmas? Why hasn't the automated blood cell counter totally replaced the blood smear? Why get tested? Why do I need to avoid live vaccines while I am taking methotrexate? Why do I need a spinal tap? Why can't my blood or urine be tested? Why does the karyotype take \n",
       "<mark class=\"entity\" style=\"background: #bfe1d9; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    several days\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DATE</span>\n",
       "</mark>\n",
       " to perform? Why does the healthcare practitioner need a \n",
       "<mark class=\"entity\" style=\"background: #bfe1d9; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    24-hour\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">TIME</span>\n",
       "</mark>\n",
       " urine sample if a random sample has already been tested? Who orders sirolimus tests? Who orders digoxin tests? What other tests might my healthcare provider recommend if my child has CF? Who orders cyclosporine tests? What type of nutrition is recommended for optimal protein levels? What treatments are recommended if I have unhealthy lipid levels? What treatments are recommended for low HDL-C levels? What treatments are recommended for high \n",
       "<mark class=\"entity\" style=\"background: #aa9cfc; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    non-HDL-C\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">PERSON</span>\n",
       "</mark>\n",
       " levels? What treatments are recommended for high LDL-C levels? What treatment is prescribed for abnormal chloride levels? What tests may be done in follow up to an abnormal liver panel to help determine the cause of liver injury? What tests are usually done to evaluate a person for Alzheimer disease? What strategies can be used to lower triglyceride levels? What steps should a pregnant woman (or anyone else) take to prevent toxoplasmosis infection? What signs and symptoms are seen with excess \n",
       "<mark class=\"entity\" style=\"background: #feca74; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    GH\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">GPE</span>\n",
       "</mark>\n",
       " and \n",
       "<mark class=\"entity\" style=\"background: #7aecec; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    IGF-1\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">ORG</span>\n",
       "</mark>\n",
       " production? What signs and symptoms are seen with deficient \n",
       "<mark class=\"entity\" style=\"background: #feca74; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    GH\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">GPE</span>\n",
       "</mark>\n",
       " and IGF-1? What should I do if I forget to save \n",
       "<mark class=\"entity\" style=\"background: #e4e7d2; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    one\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CARDINAL</span>\n",
       "</mark>\n",
       " urine sample during the collection? What should I ask my healthcare practitioner before taking prescription opioids? What puts me at risk for recurrent urinary tract infections? What proportion of infertility cases are caused by male fertility problems? What products in the \n",
       "<mark class=\"entity\" style=\"background: #feca74; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    U.S.\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">GPE</span>\n",
       "</mark>\n",
       " still contain lead, besides paint and ceramics? What type of testing is used to confirm infection with these microorganisms? What types of fish have higher levels of mercury? What types of infections can lead to sepsis? \n",
       "<mark class=\"entity\" style=\"background: #aa9cfc; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    White Blood Cell Count Reference Range\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">PERSON</span>\n",
       "</mark>\n",
       " Who is at risk of sepsis? Who is at risk for sickle cell disease? Who is at risk for liver disease and/or damage? Who is at risk for antiphospholipid syndrome? Who are universal blood donors and recipients? \n",
       "<mark class=\"entity\" style=\"background: #7aecec; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    White Blood Cell\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">ORG</span>\n",
       "</mark>\n",
       " (\n",
       "<mark class=\"entity\" style=\"background: #7aecec; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    WBC\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">ORG</span>\n",
       "</mark>\n",
       ") Tests White blood cells (WBCs) Where are sirolimus tests performed? When can my child go back to school? Where are mycophenolic acid tests performed? When to get tested? When my increased ammonia level has returned to normal, can it rise again? When is the pertussis vaccine given? When is a blood hCG test ordered instead of a urine hCG? When I look on the Internet for information about safe and unsafe drugs, different sites use different classifications and the lists are not the same. Why is this? When do people typically get measles and mumps vaccinations? Why is my travel history important to my healthcare practitioner? Why isn't a \n",
       "<mark class=\"entity\" style=\"background: #7aecec; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    Gram\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">ORG</span>\n",
       "</mark>\n",
       " stain performed on all samples sent for culture? Why isnt CA-125 used to screen for ovarian cancer? Why isnt calcitonin testing performed as a routine screen? Will I need to have this test done more than once? Will I have gestational diabetes with subsequent pregnancies? Will I have all or just some of these bone markers tested? Will I be tested if I am taking oral vancomycin? Will I be given general anesthesia for a bone marrow aspiration and/or biopsy? Will factor V \n",
       "<mark class=\"entity\" style=\"background: #feca74; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    Leiden\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">GPE</span>\n",
       "</mark>\n",
       " or PT 20210 ever go away? Will exercise, nutrition, and other lifestyle modifications help decrease my HIV viral load? Will exercise affect my creatinine levels? Will every person with cancer have a \n",
       "<mark class=\"entity\" style=\"background: #7aecec; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    CEA\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">ORG</span>\n",
       "</mark>\n",
       " test performed? Will ASCA go away once they have developed? Will anti-LKM-1 ever go away? Will an O&amp;amp;P detect all parasites? Will a high protein diet raise my total protein level? Will a blood transfusion affect reticulocyte results? Why would someone be tested for something that is legal? Why would someone be tested for a drug that is legal? Why would my healthcare provider recommend a folate supplement when I am taking methotrexate? Will latent porphyria affect my health? Will my allergies ever go away? Will my anticentromere antibody ever go away? Will phenobarbital affect other medicines that I am taking? Would a doctor ever prescribe an antibiotic without or before performing a culture? Will this test tell me the sex of my baby? Will this CF gene mutation panel detect any other genetic diseases? Will these tests always be run as a panel? Will taking aspirin at normal dosage cause complications? Will smooth muscle antibody (SMA) ever go away? Will PSA testing detect all prostate cancers? \n",
       "<mark class=\"entity\" style=\"background: #aa9cfc; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    Will PCA3\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">PERSON</span>\n",
       "</mark>\n",
       " testing detect all prostate cancers? Will my anti-dsDNA ever go away? Will my \n",
       "<mark class=\"entity\" style=\"background: #7aecec; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    WBC\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">ORG</span>\n",
       "</mark>\n",
       " antigens change? Will my platelet function change over time? Will my fungal infection eventually resolve itself without treatment? Will my ENA autoantibodies ever go away? Will my doctor order free carbamazepine or \n",
       "<mark class=\"entity\" style=\"background: #7aecec; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    carbamazepine-10,11\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">ORG</span>\n",
       "</mark>\n",
       "-epoxide frequently? Will my \n",
       "<mark class=\"entity\" style=\"background: #7aecec; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    CCP\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">ORG</span>\n",
       "</mark>\n",
       " antibody ever go away? Will my antineutrophil cytoplasmic antibodies (ANCA) ever go away? Why would my healthcare provider not monitor my ovarian cancer with HE4? Why would my healthcare practitioner want me to wait to test my lipids? Why would my healthcare practitioner order an Lp(a) more than once? Why is this pattern of prevalence seen? Why must the stool sample be fresh? Why might \n",
       "<mark class=\"entity\" style=\"background: #e4e7d2; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    one\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CARDINAL</span>\n",
       "</mark>\n",
       " person get an infection and another person not? Why might my healthcare provider repeat my eGFR test? Why might it take a long time to be diagnosed with lupus? Why might an \n",
       "<mark class=\"entity\" style=\"background: #7aecec; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    ER\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">ORG</span>\n",
       "</mark>\n",
       " doctor test a person for acetaminophen if he or she denies taking it? Why might a healthcare provider only test for a single drug? Why might a healthcare practitioner test for \n",
       "<mark class=\"entity\" style=\"background: #e4e7d2; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    only one\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CARDINAL</span>\n",
       "</mark>\n",
       " specific opioid? Why is the HIV \n",
       "<mark class=\"entity\" style=\"background: #7aecec; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    RNA\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">ORG</span>\n",
       "</mark>\n",
       " test used to test newborns for HIV infection? Why not just order an iron test? Why is the flu such a big deal? Why is the fasting blood sample collected? Why is the &lt;em&gt;T. gondii&lt;/em&gt; infection rate higher in some countries? Why is the detection of G6PD deficiency important? Why is the blood test for &lt;em&gt;H. pylori&lt;/em&gt; antibodies no longer recommended? Why isn't vancomycin more widely used? Why isn't erythropoietin measured to monitor erythropoietin drug therapy? Why must the stool sample for culture be fresh? Why not use the fFN test after \n",
       "<mark class=\"entity\" style=\"background: #bfe1d9; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    35 weeks\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DATE</span>\n",
       "</mark>\n",
       "? Why would my healthcare practitioner order a &quot;baseline&quot; serum free light chain test? Why would a separate test be ordered for fungus or an AFB smear and culture? Why would my healthcare practitioner collect \n",
       "<mark class=\"entity\" style=\"background: #e4e7d2; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    more than one\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CARDINAL</span>\n",
       "</mark>\n",
       " sputum sample? Why would my healthcare practitioner collect \n",
       "<mark class=\"entity\" style=\"background: #e4e7d2; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    more than one\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CARDINAL</span>\n",
       "</mark>\n",
       " sample? Why would malabsorption cause vitamin deficiency? Why would DNA sequencing be done as part of sickle cell testing? Why would collection of a urine sample need to be observed by a healthcare professional? Why would a urine creatinine be ordered along with a urine drug test? Why would athletes be tested for growth hormone? Why would an \n",
       "<mark class=\"entity\" style=\"background: #7aecec; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    ER\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">ORG</span>\n",
       "</mark>\n",
       " doctor want to know about all other medications and supplements that a person has taken when it is known that the person has taken a large quantity of a specific drug? Why should aspirin not be given to children? Why would an athlete be tested for sickle cell trait? Why would a healthcare practitioner choose to measure lactate in a blood sample from an artery rather than blood from a vein? Why would a chromosome analysis be done more than once? Why shouldn't I take anti-diarrheal medication if I have a Shiga toxin-producing E.coli infection of the gastrointestinal system? Why shouldn't I take an over the counter anti-diarrhea medicine when I have infectious diarrhea? Why shouldn't I take an over the counter anti-diarrhea medicine when I have diarrhea caused by &lt;em&gt;C. difficile&lt;/em&gt;? Why shouldn't I take an over the counter anti-diarrhea medicine? What other tumor marker tests may be ordered? What other tests might my healthcare practitioner do to check pancreas function? What can I do to protect against \n",
       "<mark class=\"entity\" style=\"background: #ff9561; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    West Nile\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">LOC</span>\n",
       "</mark>\n",
       " virus? What is a \n",
       "<mark class=\"entity\" style=\"background: #7aecec; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    BUN\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">ORG</span>\n",
       "</mark>\n",
       " to \n",
       "<mark class=\"entity\" style=\"background: #c887fb; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    Creatinine\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">NORP</span>\n",
       "</mark>\n",
       " ratio? What is a reticulocyte production index (RPI)? What is a reptilase time (RT) and how is it used? What is an \n",
       "<mark class=\"entity\" style=\"background: #7aecec; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    LD\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">ORG</span>\n",
       "</mark>\n",
       " isoenzymes test? What is an \n",
       "<mark class=\"entity\" style=\"background: #feca74; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    LA\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">GPE</span>\n",
       "</mark>\n",
       "-sensitive \n",
       "<mark class=\"entity\" style=\"background: #7aecec; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    PTT\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">ORG</span>\n",
       "</mark>\n",
       " and how does it differ from regular \n",
       "<mark class=\"entity\" style=\"background: #7aecec; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    PTT\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">ORG</span>\n",
       "</mark>\n",
       "? What is anion gap? What is an insulin tolerance test? What is a neural tube defect? What is an ectopic pregnancy? What is an \n",
       "<mark class=\"entity\" style=\"background: #7aecec; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    ASO\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">ORG</span>\n",
       "</mark>\n",
       " test and how is it used to detect a strep infection? What is an aldosterone/renin ratio (\n",
       "<mark class=\"entity\" style=\"background: #7aecec; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    ARR\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">ORG</span>\n",
       "</mark>\n",
       "?) What is an adrenal crisis? What is amniocentesis and how is it performed? What is a lumbar puncture (spinal tap) and how is it performed? What is a \n",
       "<mark class=\"entity\" style=\"background: #feca74; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    GH\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">GPE</span>\n",
       "</mark>\n",
       " suppression test? What is a \n",
       "<mark class=\"entity\" style=\"background: #feca74; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    GH\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">GPE</span>\n",
       "</mark>\n",
       " stimulation test? What is \n",
       "<mark class=\"entity\" style=\"background: #7aecec; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    Addison\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">ORG</span>\n",
       "</mark>\n",
       " disease? What is \n",
       "<mark class=\"entity\" style=\"background: #7aecec; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    ADA\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">ORG</span>\n",
       "</mark>\n",
       " deficiency? What is arthrocentesis and how is it performed? What is a struvite stone and what causes it? What is a water deprivation \n",
       "<mark class=\"entity\" style=\"background: #7aecec; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    ADH\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">ORG</span>\n",
       "</mark>\n",
       " stimulation test? What is HIV phenotypic resistance testing? What is macroprolactin? What is lupus anticoagulant? What is LDL particle testing? What is intraoperative PTH and why is it done? What is included in a \n",
       "<mark class=\"entity\" style=\"background: #7aecec; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    CBC\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">ORG</span>\n",
       "</mark>\n",
       "? What is immature reticulocyte fraction (\n",
       "<mark class=\"entity\" style=\"background: #7aecec; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    IRF\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">ORG</span>\n",
       "</mark>\n",
       ")? What is HIV provirus? What is HIT type I and how does it differ from HIT type II? What is a water loading \n",
       "<mark class=\"entity\" style=\"background: #7aecec; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    ADH\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">ORG</span>\n",
       "</mark>\n",
       " suppression test? What is hepatitis D (HDV) and how is it associated with hepatitis B? What is graft versus host disease (GVHD)? What is gluten and what contains gluten? What is FTI? What is creatine? If I take creatine, will my creatinine levels go up? What is \n",
       "<mark class=\"entity\" style=\"background: #7aecec; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    CK\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">ORG</span>\n",
       "</mark>\n",
       " index? What is \n",
       "<mark class=\"entity\" style=\"background: #aa9cfc; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    Bartter\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">PERSON</span>\n",
       "</mark>\n",
       " syndrome? What is a corrected reticulocyte count (\n",
       "<mark class=\"entity\" style=\"background: #7aecec; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    CRC\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">ORG</span>\n",
       "</mark>\n",
       ")? What is a BUN/Creatinine ratio? What other tests might my doctor order to diagnose my flu-like symptoms? What is a \n",
       "<mark class=\"entity\" style=\"background: #e4e7d2; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    3rd\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">ORDINAL</span>\n",
       "</mark>\n",
       " generation \n",
       "<mark class=\"entity\" style=\"background: #7aecec; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    TSH\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">ORG</span>\n",
       "</mark>\n",
       " and an ultrasensitive \n",
       "<mark class=\"entity\" style=\"background: #7aecec; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    TSH\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">ORG</span>\n",
       "</mark>\n",
       "? What does heart attack mean? What do changes in my \n",
       "<mark class=\"entity\" style=\"background: #7aecec; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    ESR\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">ORG</span>\n",
       "</mark>\n",
       " mean? What diseases can a \n",
       "<mark class=\"entity\" style=\"background: #7aecec; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    CBC\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">ORG</span>\n",
       "</mark>\n",
       " detect? What could cause \n",
       "<mark class=\"entity\" style=\"background: #7aecec; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    apoB\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">ORG</span>\n",
       "</mark>\n",
       " and \n",
       "<mark class=\"entity\" style=\"background: #7aecec; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    LDL\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">ORG</span>\n",
       "</mark>\n",
       " levels to stay high despite lifestyle changes? What conditions other than liver problems can cause increased AST? What conditions other than liver problems can cause increased ALT? What conditions or other factors can affect haptoglobin levels? What conditions are treated with growth hormone therapy? What complications can occur if the infection is not properly treated? What causes the autoimmune disorders associated with HLA-B27? What causes sarcoidosis? What causes primary biliary cholangitis (\n",
       "<mark class=\"entity\" style=\"background: #7aecec; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    PBC\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">ORG</span>\n",
       "</mark>\n",
       ")? What causes male infertility? What causes inflammation? What can I do to take care of myself if I have alpha-1 antitrypsin (AAT) deficiency? What can I do to reduce my exposure to mercury? What can I do to raise my apo A-I? What does the glucose drink taste like? Is the \n",
       "<mark class=\"entity\" style=\"background: #7aecec; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    PTT\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">ORG</span>\n",
       "</mark>\n",
       " always used to monitor heparin therapy? What does the test result mean (children, teens and young adults)? What foods are high in calcium? What if I have a \n",
       "<mark class=\"entity\" style=\"background: #7aecec; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    TST\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">ORG</span>\n",
       "</mark>\n",
       " and it is \n",
       "<mark class=\"entity\" style=\"background: #bfe1d9; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    more than 72 hours\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">TIME</span>\n",
       "</mark>\n",
       " before I go back to have it evaluated? What if I am not sure if I am having a heart attack? What happens if my infection goes untreated? What happens if my healthcare practitioner needs more information than the \n",
       "<mark class=\"entity\" style=\"background: #7aecec; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    Gram\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">ORG</span>\n",
       "</mark>\n",
       " stain provides? What happened before the \n",
       "<mark class=\"entity\" style=\"background: #ff9561; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    RhIg\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">LOC</span>\n",
       "</mark>\n",
       " (Rh immune globulin) injection was developed? What foods contain the most iron? What foods can I eat to increase the iron in my diet? What food and medications can affect PT and \n",
       "<mark class=\"entity\" style=\"background: #7aecec; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    INR\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">ORG</span>\n",
       "</mark>\n",
       " results? What does vitamin D have to do with PTH? What else is methotrexate used for? What else is known about C-peptide? What else can cause a low platelet count (thrombocytopenia)? What else can cause acute diarrhea? What drugs can cause rhabdomyolysis? What drugs can affect the serotonin test? What do the results mean? What is paracentesis and how is it performed? What is pericardiocentesis and how is it performed? What is primary amyloidosis? What is PSA isoform p2PSA? What other tests are used to evaluate liver disorders? What other tests are used to diagnose sarcoidosis? What other tests are available for allergy testing? What other stool screening tests are available? What other procedures will my healthcare practitioner likely order along with CA 19-9? What other procedures might my healthcare practitioner order if my D-dimer is positive? What other minerals are required by the body? What other micronutrients are required by the body? What other lab tests might be ordered after I begin taking lithium? What other lab tests might be done? What other lab tests may be performed? What other laboratory tests might my healthcare practitioner perform? What other laboratory tests might be done if I or my child has a normal elastase test? What other laboratory tests might be done if I or my child has a negative cymotrypsin test? What other laboratory tests may be done if I have a bone disorder? What other findings might suggest kidney dysfunction? What other factors affect the transferrin level? What other tests are used to help determine the risk of preterm delivery? What other tests are used with the blood urea nitrogen test to check how my kidneys are functioning? What other tests besides those included in a renal panel might be ordered to assess kidney function? What other tests may be performed? What other tests might my doctor order in evaluating me for \n",
       "<mark class=\"entity\" style=\"background: #7aecec; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    RA\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">ORG</span>\n",
       "</mark>\n",
       "? What other tests might my doctor order besides ESR? What other tests might be ordered in emergency or overdose cases? What other tests might be ordered? What other tests might be done? What other tests may be used to help determine the cause of liver damage? What other tests may be performed to help determine the cause of liver damage? What other tests may be done to rule out secondary (reactive) causes of increased eosinophils? What other tests could be useful in assessing \n",
       "<mark class=\"entity\" style=\"background: #7aecec; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    PTH\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">ORG</span>\n",
       "</mark>\n",
       "? What other tests may be done to evaluate kidney function? What other tests may be done to evaluate an elevated prolactin? What other tests may be done in addition to hemoglobin? What other tests may be done in addition to \n",
       "<mark class=\"entity\" style=\"background: #7aecec; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    CSF\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">ORG</span>\n",
       "</mark>\n",
       " testing? What other tests may be done in addition to a hematocrit? What other tests may be done if a systemic bacterial infection or sepsis is suspected? What other tests detect a heart attack? What other conditions may alter ferritin levels? What other antiepileptic drugs (AEDs) are there? What occupations might result in lead exposure? What is the difference between multidrug-resistant \n",
       "<mark class=\"entity\" style=\"background: #7aecec; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    TB\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">ORG</span>\n",
       "</mark>\n",
       " (\n",
       "<mark class=\"entity\" style=\"background: #7aecec; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    MDR\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">ORG</span>\n",
       "</mark>\n",
       "-TB) and extensively-resistant \n",
       "<mark class=\"entity\" style=\"background: #7aecec; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    TB\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">ORG</span>\n",
       "</mark>\n",
       " (\n",
       "<mark class=\"entity\" style=\"background: #7aecec; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    XDR-TB\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">ORG</span>\n",
       "</mark>\n",
       ")? What is the difference between urine osmolality and specific gravity? What is the difference between tests for fibrinogen, d-dimer, and fibrin degradation products (FDP)? What is the difference between regular CRP and \n",
       "<mark class=\"entity\" style=\"background: #7aecec; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    hs-CRP\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">ORG</span>\n",
       "</mark>\n",
       " tests? What is the difference between primary \n",
       "<mark class=\"entity\" style=\"background: #7aecec; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    CVD\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">ORG</span>\n",
       "</mark>\n",
       " treatment and secondary treatment? What is the difference between prealbumin, serum/plasma albumin, and urine albumin tests? What is the difference between P-amylase and S-amylase? What is the difference between osmolality and osmolarity? What is the difference between group A and group B streptococcus? What is the formula used to calculate LDL-C? What is the difference between \n",
       "<mark class=\"entity\" style=\"background: #aa9cfc; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    EGFR\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">PERSON</span>\n",
       "</mark>\n",
       " (also known as \n",
       "<mark class=\"entity\" style=\"background: #7aecec; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    HER-1\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">ORG</span>\n",
       "</mark>\n",
       ") and HER-2? What is the difference between \n",
       "<mark class=\"entity\" style=\"background: #7aecec; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    Cushing\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">ORG</span>\n",
       "</mark>\n",
       " disease and \n",
       "<mark class=\"entity\" style=\"background: #7aecec; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    Cushing\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">ORG</span>\n",
       "</mark>\n",
       " syndrome? What is the difference between \n",
       "<mark class=\"entity\" style=\"background: #7aecec; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    CRP\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">ORG</span>\n",
       "</mark>\n",
       " and \n",
       "<mark class=\"entity\" style=\"background: #7aecec; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    hs-CRP\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">ORG</span>\n",
       "</mark>\n",
       " tests? What is the difference between chronic myelogenous leukemia and chronic \n",
       "<mark class=\"entity\" style=\"background: #feca74; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    myeloid\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">GPE</span>\n",
       "</mark>\n",
       " leukemia? What is the difference between celiac disease and an allergy to wheat and other grains? What is the clinical relevance of factor V R2 mutation? What is reverse \n",
       "<mark class=\"entity\" style=\"background: #e4e7d2; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    T3\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CARDINAL</span>\n",
       "</mark>\n",
       "? What is the formula for calculating osmolality? What is the lactate/pyruvate ratio and how is it used? What medications can affect a \n",
       "<mark class=\"entity\" style=\"background: #7aecec; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    TSH\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">ORG</span>\n",
       "</mark>\n",
       " test? What is the treatment of peptic ulcer caused by &lt;em&gt;H. pylori&lt;/em&gt;? What kind of procedures might follow a positive FOBT or \n",
       "<mark class=\"entity\" style=\"background: #7aecec; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    FIT\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">ORG</span>\n",
       "</mark>\n",
       "? What is \n",
       "<mark class=\"entity\" style=\"background: #aa9cfc; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    Zollinger-Ellison\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">PERSON</span>\n",
       "</mark>\n",
       " syndrome? What is \n",
       "<mark class=\"entity\" style=\"background: #aa9cfc; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    von Willebrand\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">PERSON</span>\n",
       "</mark>\n",
       " factor? What is VLDL and how does it relate to triglyceride? What is transient hypogammaglobulinemia of infancy (\n",
       "<mark class=\"entity\" style=\"background: #7aecec; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    THI\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">ORG</span>\n",
       "</mark>\n",
       ")? What is thoracentesis and how is it performed? What is \n",
       "<mark class=\"entity\" style=\"background: #aa9cfc; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    Thimerosal\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">PERSON</span>\n",
       "</mark>\n",
       "? What is the treatment for sepsis? What is \n",
       "<mark class=\"entity\" style=\"background: #7aecec; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    the Prostate Health\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">ORG</span>\n",
       "</mark>\n",
       " Index (PHI)? What is the treatment for \n",
       "<mark class=\"entity\" style=\"background: #7aecec; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    RSV\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">ORG</span>\n",
       "</mark>\n",
       "? What is the treatment for male infertility? What is the treatment for hemoglobinopathy? What is the treatment for HCV? What is the treatment for an electrolyte imbalance? What is the \n",
       "<mark class=\"entity\" style=\"background: #e4e7d2; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    T3\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CARDINAL</span>\n",
       "</mark>\n",
       " uptake test? What is the recommended dietary salt intake? Is there a blood test for \n",
       "<mark class=\"entity\" style=\"background: #aa9cfc; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    Legionella\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">PERSON</span>\n",
       "</mark>\n",
       "? Is it necessary to repeat a \n",
       "<mark class=\"entity\" style=\"background: #7aecec; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    KRAS\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">ORG</span>\n",
       "</mark>\n",
       " mutation test? Is the \n",
       "<mark class=\"entity\" style=\"background: #7aecec; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    CK\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">ORG</span>\n",
       "</mark>\n",
       " test used for purposes other than detecting skeletal muscle damage? Can results of testing be used to determine the course of my cancer (prognosis)? Can preterm labor and delivery be prevented? Can porphyrin tests be done at my healthcare practitioner's office? Can platelet function assays be used to assess clopidogrel response? Can other drugs I take affect theophylline levels? Can my test be performed in my healthcare practitioner's office? Can my state of mind really affect my test results? Can my \n",
       "<mark class=\"entity\" style=\"background: #7aecec; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    RBC\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">ORG</span>\n",
       "</mark>\n",
       " count be tested at my doctors office? Can my MTHFR genes change? Can my hematocrit be tested at home? Can my healthcare practitioner choose from a variety of platelet function tests? Can my HDL-C be too high? Can my GGT level be elevated if I don't have any symptoms? Can my doctor diagnose tuberculosis without testing my pleural fluid? Can mycoplasma infections be avoided? Can my blood be tested for \n",
       "<mark class=\"entity\" style=\"background: #7aecec; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    ADA\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">ORG</span>\n",
       "</mark>\n",
       "? Can myasthenia gravis affect my heart? Can \n",
       "<mark class=\"entity\" style=\"background: #aa9cfc; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    MG\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">PERSON</span>\n",
       "</mark>\n",
       " be passed from \n",
       "<mark class=\"entity\" style=\"background: #e4e7d2; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    one\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CARDINAL</span>\n",
       "</mark>\n",
       " person to another? Can protein be measured in samples other than blood? Can serum free light chain testing be done at home or in my healthcare practitioner's office? Is the \n",
       "<mark class=\"entity\" style=\"background: #7aecec; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    CALR\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">ORG</span>\n",
       "</mark>\n",
       " mutation hereditary? Can someone prevent cryoglobulin-related symptoms? Can the test be performed in my healthcare practitioner's office? Can the test be done in my doctor's office? Can these tests be used to diagnose diabetes? Can the reticulocyte count be done on the same tube of blood as the \n",
       "<mark class=\"entity\" style=\"background: #7aecec; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    RBC\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">ORG</span>\n",
       "</mark>\n",
       " count or \n",
       "<mark class=\"entity\" style=\"background: #7aecec; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    CBC\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">ORG</span>\n",
       "</mark>\n",
       "? Can the \n",
       "<mark class=\"entity\" style=\"background: #aa9cfc; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    LH\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">PERSON</span>\n",
       "</mark>\n",
       " test be used to tell if I have ovulated? Can the heparin-induced thrombocytopenia (HIT) antibody test be done in my healthcare practitioner's office? Can the fecal fat test be done in my doctor's office? Can the ENA panel be performed at my healthcare practitioner's office? Can the \n",
       "<mark class=\"entity\" style=\"background: #7aecec; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    DHEAS\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">ORG</span>\n",
       "</mark>\n",
       " test be performed in my healthcare practitioner's office? Can the \n",
       "<mark class=\"entity\" style=\"background: #7aecec; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    ASO\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">ORG</span>\n",
       "</mark>\n",
       " test be performed in my doctor's office? Can the anti-dsDNA test be performed at my healthcare practitioner's office? Can the \n",
       "<mark class=\"entity\" style=\"background: #7aecec; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    ANCA\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">ORG</span>\n",
       "</mark>\n",
       " test be performed at my local lab? Can \n",
       "<mark class=\"entity\" style=\"background: #7aecec; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    THC\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">ORG</span>\n",
       "</mark>\n",
       " screening detect if Im using medical marijuana or a prescribed form of cannabis? Can testing for mycoplasma be performed in my doctor's office? Can testing be performed in my healthcare practitioner's office? Can taking too many vitamin \n",
       "<mark class=\"entity\" style=\"background: #7aecec; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    B12\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">ORG</span>\n",
       "</mark>\n",
       " and folic acid supplements hurt me? Can stones form in other parts of the urinary tract besides the kidney? Can medications that I am taking affect the amylase level? Can medical providers release medical ethanol test results for legal purposes? Can lupus anticoagulant interfere with the ACT test? Can leptin testing be performed in my doctor's office? Can I skip the digital rectal exam (\n",
       "<mark class=\"entity\" style=\"background: #7aecec; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    DRE\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">ORG</span>\n",
       "</mark>\n",
       ") and just collect a urine sample? Can I receive \n",
       "<mark class=\"entity\" style=\"background: #7aecec; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    ALK\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">ORG</span>\n",
       "</mark>\n",
       " kinase inhibitor drug therapy and still not benefit from it? Can I prevent, decrease, or get rid of parietal cell antibodies? Can I perform this test at home? Can I monitor triglyceride levels at home? Can I monitor my childs type \n",
       "<mark class=\"entity\" style=\"background: #e4e7d2; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    1\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CARDINAL</span>\n",
       "</mark>\n",
       " diabetes with a \n",
       "<mark class=\"entity\" style=\"background: #7aecec; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    CGM\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">ORG</span>\n",
       "</mark>\n",
       " device? Can I lower my IL-6 level? Can IL-6 be measured in samples other than blood? Can I just test my blood or urine instead of the stone? Can I just order the test on the internet and perform it at home? Can I just do the screening fecal fat test and not the \n",
       "<mark class=\"entity\" style=\"background: #bfe1d9; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    72-hour\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">TIME</span>\n",
       "</mark>\n",
       " test? Can I have VWD and not know it? Can I have the haptoglobin test done in my healthcare practitioner's office? Can I have the ceruloplasmin test done in my healthcare provider's office? Can I have oats in my diet? Can I have my test performed in my healthcare practitioners office? Can I have my level tested at home? Can I still get the flu if I've had the vaccine? Can I take an \n",
       "<mark class=\"entity\" style=\"background: #7aecec; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    ALK\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">ORG</span>\n",
       "</mark>\n",
       " kinase inhibitor drug therapy without being tested? Can I test for fructosamine at home? Can I test myself for HCV at home? Can Legionella bacterial contamination and infection be prevented? Can I use a device for longer than indicated? Can I test vancomycin levels at home? Can I test positive from secondhand smoke? Can I test negative and still have the flu? Can I test negative and still have a respiratory infection? Can I test my valproic acid level at my doctor's office? Can I test my phenytoin level at home? Can I test for ketones in my urine instead of my blood? Can I test my lithium level at home? Can I test my lipids at home? Can I test my levetiracetam level at my healthcare practitioner's office? Can I test my LDL cholesterol at home? Can I test my hemoglobin at home? Can I test my blood glucose levels at home? Can I test for protein in my urine at home? Can the thrombin time be performed in my doctor's office? Can the total IgE test be performed in my doctors office? Can this test be done at my healthcare practitioners office? Details on Red Blood Cell Irregularities (\n",
       "<mark class=\"entity\" style=\"background: #7aecec; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    RBC\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">ORG</span>\n",
       "</mark>\n",
       " morphology) Does everyone metabolize alcohol at the same rate? Does early detection of beta cell destruction allow its prevention? Does donating blood affect my iron level? Does chickenpox leave scars? Does anemia due to iron deficiency happen quickly or does it take a long time? Do elevated lipase levels always mean I have a pancreatic condition? Do elevated amylase levels always mean that I have a pancreatic condition? Do EBV infection and mono occur throughout the world? Do diet and nutrition help keep RBCs at healthy levels? Do creatinine levels change with age? Do chickenpox and shingles occur throughout the world? Do any forms of tobacco not contain nicotine? Do all states require or offer newborn screening for CF? Do I need to request it? Do all people with iron deficiency have anemia? What are the symptoms? Do all people with iron deficiency have anemia? Do all men have estrogens? Do adults get mono? Does everyone treated for &lt;em&gt;H. pylori&lt;/em&gt; get better? Does everyone with elevated androstenedione have symptoms? Does everyone with elevated DHEAS have symptoms? Does lactose intolerance only apply to breast milk and cow's milk? Does the amount of plasma free metanephrines detected correspond to the size of the tumor? Does testing non-HDL-C have some advantages compared to LDL-C? Does soy milk have lactose in it? Does ovarian cancer run in families? Does \n",
       "<mark class=\"entity\" style=\"background: #7aecec; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    NIPS\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">ORG</span>\n",
       "</mark>\n",
       " test for open neural tube defects such as spina bifida? Does my sample for a \n",
       "<mark class=\"entity\" style=\"background: #7aecec; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    DHEAS\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">ORG</span>\n",
       "</mark>\n",
       " level have to be drawn at a certain time of day like other hormone tests? Does my risk of being a carrier vary depending on my ethnic background? Does kidney damage go away? Does everyone with &lt;em&gt;H. pylori&lt;/em&gt; get ulcers? Does it matter which antibodies I have? Does it matter whether I have a lactoferrin or a calprotectin test? Does histamine do anything besides cause allergic reaction symptoms? Does HER2-targeted therapy work for every tumor that is HER2-positive? Does having chlamydia put me at greater risk for other STDs? Does \n",
       "<mark class=\"entity\" style=\"background: #7aecec; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    GBS\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">ORG</span>\n",
       "</mark>\n",
       " cause serious infections in adults? Does everyone with HIT antibodies develop HIT II? Details on White Blood Cells Details on CSF Tests Can this test be done at my local lab? Details on CBC Results Can vitamin A testing be done in my healthcare practitioner's office? Can vegetarians meet their phosphorus needs without resorting to meat or dairy? Can urine samples be tested for glucose? Can urine be tested instead of blood? Can tryptase testing be done in my doctor's office? Can TNF inhibitor therapy cure my autoimmune disorder? Cant I just take stomach medicines to address my excess gastrin and stomach acid? Can thyroid antibody testing be done in my doctor's office? Can thyroglobulin testing be performed in my healthcare practitioner's office? Can thrombin time be used for monitoring dabigatran therapy? Can this test be performed in my healthcare provider's office? Can this test be performed in my healthcare practitioners office? Can this test be performed in my healthcare practitioner's office? Can this test be performed at my healthcare practitioners office? Can this test be done in my doctor's office? Can this test be done in a doctor's office? Can this test be done at my local laboratory? Can \n",
       "<mark class=\"entity\" style=\"background: #7aecec; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    VWF\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">ORG</span>\n",
       "</mark>\n",
       " testing be performed in my doctor's office? Can warfarin sensitivity testing be done in my doctor's office? Can water be tested for \n",
       "<mark class=\"entity\" style=\"background: #aa9cfc; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    Legionella\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">PERSON</span>\n",
       "</mark>\n",
       " bacteria? Choride Reference Range CSF Physical Features (pressure and appearance) CSF Chemical Tests Crystals Could I calculate my own eGFR? Could any medications I may be taking have an effect on my homocysteine level? \n",
       "<mark class=\"entity\" style=\"background: #aa9cfc; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    Color CO2 Reference Range Chloride Reference Range Can\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">PERSON</span>\n",
       "</mark>\n",
       " whooping cough testing be done in my healthcare practitioner's office? \n",
       "<mark class=\"entity\" style=\"background: #7aecec; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    Chemical Exam Cell Counts, Differential and Microscopic Exam Casts Can Zika\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">ORG</span>\n",
       "</mark>\n",
       " virus be passed from person to person? Can Zika be prevented? Can you \n",
       "<mark class=\"entity\" style=\"background: #aa9cfc; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    outgrow\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">PERSON</span>\n",
       "</mark>\n",
       " or desensitize yourself to celiac disease? Can you get shingles by being exposed to someone who has active symptoms of shingles? Can I have my blood tested for beta amyloid and tau instead of my \n",
       "<mark class=\"entity\" style=\"background: #7aecec; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    CSF\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">ORG</span>\n",
       "</mark>\n",
       "? Can I have liver disease if I feel fine? Can I have kidney disease if I feel fine? Are there other ways of testing for resistance? Are those parasitic worms I'm seeing in my stool sample? Are the \n",
       "<mark class=\"entity\" style=\"background: #e4e7d2; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    two\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CARDINAL</span>\n",
       "</mark>\n",
       " tests always done together? Are these tests always performed together as a panel? Are there ways to test for G6PD deficiency other than enzyme testing? Are there ways to protect myself and my family if I have a job where I may be exposed to lead? Are there ways to protect myself and my family from lead exposure? Are there warning signs for abnormally low hemoglobin levels? Are there vaccines for arboviruses? Are there treatments available for decreased or dysfunctional fibrinogen? Are there things that I can do to raise or lower my \n",
       "<mark class=\"entity\" style=\"background: #7aecec; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    TSH\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">ORG</span>\n",
       "</mark>\n",
       " level? Are there things that I can do to raise or lower my free T4 level? Are there symptoms I should recognize if my RBCs are dangerously low or high? Are there symptoms associated with decreased immunoglobulins? Are there over-the-counter (OTC) at-home FOBTs and are they just as good as stool tests performed by laboratories? Are there other ways to test for intestinal parasites besides a stool exam? Are there other ways to test for celiac disease? Are there other ways to measure lactate than by sending a blood sample to the lab for testing? Are thyroid antibodies part of routine thyroid testing? Ascorbic Acid (Vitamin C) \n",
       "<mark class=\"entity\" style=\"background: #aa9cfc; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    Bacteria\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">PERSON</span>\n",
       "</mark>\n",
       ", yeast and parasites Besides HCV testing, what other tests might be done? Besides ovarian tumors, is \n",
       "<mark class=\"entity\" style=\"background: #7aecec; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    inhibin\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">ORG</span>\n",
       "</mark>\n",
       " testing used for other conditions? Besides \n",
       "<mark class=\"entity\" style=\"background: #7aecec; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    NIPS\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">ORG</span>\n",
       "</mark>\n",
       ", what are the other options for prenatal screening? Besides lung cancer, are there other types of cancers that have increased \n",
       "<mark class=\"entity\" style=\"background: #aa9cfc; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    EGFR\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">PERSON</span>\n",
       "</mark>\n",
       " protein? Besides inhibin B, what other tests may be done? Besides infertility, is \n",
       "<mark class=\"entity\" style=\"background: #7aecec; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    inhibin\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">ORG</span>\n",
       "</mark>\n",
       " testing used for other conditions? Besides \n",
       "<mark class=\"entity\" style=\"background: #7aecec; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    HPV\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">ORG</span>\n",
       "</mark>\n",
       ", what are other risk factors for cervical cancer in women? Besides HER2, what other laboratory tests may my healthcare provider order on my breast cancer tissue? Besides glucose, what other tests might be done? Basophils Besides blood and urine, can other body fluids be tested for glucose? Besides \n",
       "<mark class=\"entity\" style=\"background: #7aecec; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    ASCA\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">ORG</span>\n",
       "</mark>\n",
       ", what other testing may be done? Besides antibody tests, what other tests may be ordered? Besides antibody and molecular tests, are there other ways of testing for toxoplasmosis? Besides a neuroendocrine tumor, what else can cause elevated \n",
       "<mark class=\"entity\" style=\"background: #c887fb; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    CgA\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">NORP</span>\n",
       "</mark>\n",
       " levels? Besides \n",
       "<mark class=\"entity\" style=\"background: #7aecec; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    ANCA\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">ORG</span>\n",
       "</mark>\n",
       ", what other lab tests may be done? Besides \n",
       "<mark class=\"entity\" style=\"background: #7aecec; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    ABO\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">ORG</span>\n",
       "</mark>\n",
       " and Rh, are there other types of red blood cell antigens? Are there other ways to estimate or determine the glomerular filtration rate (GFR) of my kidneys? Are there other uses for vitamin D? Besides \n",
       "<mark class=\"entity\" style=\"background: #7aecec; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    TB\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">ORG</span>\n",
       "</mark>\n",
       ", what other types of mycobacteria can be identified with AFB testing? Are there other uses for the SHBG test? Are there any symptoms associated with a high level of triglycerides? Are there any side effects of performing a \n",
       "<mark class=\"entity\" style=\"background: #7aecec; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    CEA\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">ORG</span>\n",
       "</mark>\n",
       " test? Are there any other genetic tests that will diagnose AD? Are the illicit synthetic forms of marijuana such as K2 and Spice the same thing as \n",
       "<mark class=\"entity\" style=\"background: #7aecec; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    THC\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">ORG</span>\n",
       "</mark>\n",
       " and can they be detected by \n",
       "<mark class=\"entity\" style=\"background: #aa9cfc; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    marijuana\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">PERSON</span>\n",
       "</mark>\n",
       " testing? Are some people at a higher risk for developing a pheochromocytoma or neuroblastoma? Are some antibiotics more likely to cause antibiotic-related diarrhea? Are people who have no symptoms ever tested for \n",
       "<mark class=\"entity\" style=\"background: #7aecec; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    WNV\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">ORG</span>\n",
       "</mark>\n",
       "? Are myoglobin tests used to help diagnose heart attacks? Are men tested for progesterone? Are men screened for \n",
       "<mark class=\"entity\" style=\"background: #7aecec; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    HPV\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">ORG</span>\n",
       "</mark>\n",
       " infection? Are calcitonin levels elevated in other conditions besides c-cell hyperplasia and medullary thyroid cancer? Are arboviruses something I should worry about when I travel? Are any other procedures done to help evaluate conditions involving the peritoneum? Are any other methods used for immunophenotyping? Are antibiotics useful when I have \n",
       "<mark class=\"entity\" style=\"background: #7aecec; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    RSV\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">ORG</span>\n",
       "</mark>\n",
       "? Are all \n",
       "<mark class=\"entity\" style=\"background: #7aecec; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    CGM\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">ORG</span>\n",
       "</mark>\n",
       " devices the same? A healthcare practitioner correctly places a tuberculin skin test in a recipient&amp;#039;s forearm. Image credit: \n",
       "<mark class=\"entity\" style=\"background: #7aecec; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    CDC\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">ORG</span>\n",
       "</mark>\n",
       " Are there conditions other than vasculitis and inflammatory bowel disease that can cause a positive ANCA? Are there dietary recommendations for chloride? Are there different ways to measure testosterone as well as free and bioavailable testosterone? Are there other reasons to do a paracentesis? Are there other types of tests available for EBV? Are there other types of testing that evaluate \n",
       "<mark class=\"entity\" style=\"background: #aa9cfc; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    EGFR\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">PERSON</span>\n",
       "</mark>\n",
       " in tumors? Are there other types of strep bacteria that can cause a sore throat? Are there other tumor markers used in ovarian cancer? Are there other things that cause anemia besides iron deficiency? Are there other reasons to do a thoracentesis? Are there other reasons to do a pericardiocentesis? Are there other reasons to do an arthrocentesis? Are there home test kits available to test my urine? Are there other reasons to do a lumbar puncture? Are there other reasons for having increased urine albumin levels? Are there other genetic changes that my healthcare practitioner may test for with leukemia? Are there other genetic abnormalities associated with neoplastic hypereosinophilia or hypereosinophilic syndrome (HE/HES)? Are there other causes of \n",
       "<mark class=\"entity\" style=\"background: #7aecec; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    VWF\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">ORG</span>\n",
       "</mark>\n",
       " deficiency besides inherited causes? Are there other adipokines besides leptin? Are there medications that can affect \n",
       "<mark class=\"entity\" style=\"background: #7aecec; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    ADH\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">ORG</span>\n",
       "</mark>\n",
       " levels? Besides sirolimus testing, what other tests might be done and why? Besides tests for \n",
       "<mark class=\"entity\" style=\"background: #7aecec; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    Legionella\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">ORG</span>\n",
       "</mark>\n",
       " pneumophila, what other testing may be done? Can I have ketosis or ketoacidosis and not know it? Can either blood or urine be used for the \n",
       "<mark class=\"entity\" style=\"background: #7aecec; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    MMA\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">ORG</span>\n",
       "</mark>\n",
       " test? Can I do this test at home? Can I do anything to increase my production of lactase? Can I do anything to change my antithrombin activity or quantity? Can I do an insulin test at home? Can I do a C-peptide test at home like I can when I check my blood glucose? Can I develop rheumatic fever or glomerulonephritis at the same time as my strep throat? Can I choose either a blood (total or free) or urine copper test? Can I change my B vitamin levels? Can I buy a \n",
       "<mark class=\"entity\" style=\"background: #7aecec; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    CGM\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">ORG</span>\n",
       "</mark>\n",
       " device over-the-counter? Can I be vaccinated against HCV? Can I be tested for cholinesterase in my healthcare provider's office? Can I be tested for \n",
       "<mark class=\"entity\" style=\"background: #7aecec; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    CCP\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">ORG</span>\n",
       "</mark>\n",
       " antibody in my doctor's office? Can I be fired from my job for testing positive for marijuana in areas of the \n",
       "<mark class=\"entity\" style=\"background: #feca74; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    U.S.\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">GPE</span>\n",
       "</mark>\n",
       " where it has been legalized? Can I be colonized with MRSA and not know it? Can histamine testing be done in my healthcare practitioner's office? Can glucose testing be done when I have not fasted? Can gestational trophoblastic disease (GTD) be prevented? Can I drink water before or during the test? Can I get diabetic ketoacidosis if I have type \n",
       "<mark class=\"entity\" style=\"background: #e4e7d2; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    2\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CARDINAL</span>\n",
       "</mark>\n",
       " diabetes? Can I get HTLV-I/II from donating blood? Can I have an intrinsic factor antibody test done at my doctor's office? Can I have iron deficiency if I feel fine? Can I have \n",
       "<mark class=\"entity\" style=\"background: #7aecec; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    CAH\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">ORG</span>\n",
       "</mark>\n",
       " if no CYP21A2 gene mutations were detected during genetic testing? Can I have B12 and folate tests done in my doctor's office? Can I have a tuberculosis (\n",
       "<mark class=\"entity\" style=\"background: #7aecec; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    TB\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">ORG</span>\n",
       "</mark>\n",
       ") infection and not be sick? Can I have a sweat chloride test done at my healthcare provider's office? Can I have a normal pregnancy after having GTD? Can I have an Lp(a) test done in my healthcare practitioner's office? Can I have an inhibin test to screen for ovarian tumors or ovarian cancer? Can I get infectious mononucleosis more than once? Can I have an \n",
       "<mark class=\"entity\" style=\"background: #7aecec; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    AMA\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">ORG</span>\n",
       "</mark>\n",
       " or \n",
       "<mark class=\"entity\" style=\"background: #7aecec; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    AMA\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">ORG</span>\n",
       "</mark>\n",
       "-M2 test done in my healthcare practitioner's office? Can I have an abnormal PTH level without having symptoms? Can I have abnormal test results and not have liver disease? Can I have abnormal test results and not have kidney disease? Can I get rid of intrinsic factor antibodies? Can I get my vitamin D from yogurt and cheese? Can I get MRSA more than once? Can flow cytometry immunophenotyping be done at my local laboratory? Can e-cigarettes and vaping cause a positive nicotine result? Besides urine and saliva, what other types of samples may be used for marijuana testing? Can EBV cause other serious illnesses? Can an anti-DNase B or an \n",
       "<mark class=\"entity\" style=\"background: #7aecec; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    ASO\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">ORG</span>\n",
       "</mark>\n",
       " be used to diagnose strep throat? Can an \n",
       "<mark class=\"entity\" style=\"background: #7aecec; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    AFP\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">ORG</span>\n",
       "</mark>\n",
       " test be performed at home or in my healthcare practitioner's office? Can amniotic fluid analysis be performed in my healthcare practitioner's office? Can a healthy diet and nutrition help keep optimal hemoglobin levels? Can a fructosamine test be used to screen for diabetes? Can adequate erythropoietin production by my kidneys be restored? Can a CRP test be performed in my doctor's office? Can a chromosome analysis be performed in my healthcare provider's office? Can a blood test be substituted for a stool calprotectin test? Can a blood sample from a fingerstick be used to diagnose diabetes? Can a blood sample be used instead of a tissue sample to perform these tests? BUN Reference Range Blood (\n",
       "<mark class=\"entity\" style=\"background: #aa9cfc; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    Hemoglobin\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">PERSON</span>\n",
       "</mark>\n",
       ") and \n",
       "<mark class=\"entity\" style=\"background: #aa9cfc; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    Myoglobin\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">PERSON</span>\n",
       "</mark>\n",
       " Blood Creatinine Reference Range Bilirubin Bicarbonate (Total CO2) Reference Range Besides ZPP and lead levels, what other tests might my doctor order to monitor exposure to lead? Can an apo A-I test be performed in my doctor's office or at home? Can an apo B test be performed in my doctor's office or at home? Can an HIV RNA test be used to screen for HIV? Can bacterial pneumonia be prevented? Can disorders detected through amniotic fluid analysis be prevented? Can diabetes insipidus be treated? Can dengue fever be prevented? Can dengue fever be passed from person to person? Can cystatin C be measured in my urine? Can clopidogrel resistance testing be done in my healthcare provider's office? Can B vitamins be measured at home or in my doctor's office? Can babies get \n",
       "<mark class=\"entity\" style=\"background: #7aecec; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    GBS\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">ORG</span>\n",
       "</mark>\n",
       " infections \n",
       "<mark class=\"entity\" style=\"background: #bfe1d9; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    more than 7 days\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DATE</span>\n",
       "</mark>\n",
       " after they are born? Can anticentromere testing be done at my healthcare practitioner's office? Can a white blood cell (\n",
       "<mark class=\"entity\" style=\"background: #7aecec; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    WBC\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">ORG</span>\n",
       "</mark>\n",
       ") differential be performed on samples other than blood? Can a \n",
       "<mark class=\"entity\" style=\"background: #7aecec; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    WBC\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">ORG</span>\n",
       "</mark>\n",
       " count be performed on a sample other than blood? Can a urine culture be used to test for infections other than UTIs, such as sexually transmitted diseases (STDs)? Can a urinalysis be done in my healthcare practitioners office? Can a throat swab be used instead of a nasopharyngeal sample from my nose? Can ASO be used to diagnose strep throat? Can a pleural effusion go away on its own? Does the amount of urine metanephrines detected correspond to the size of the tumor? Does the Epstein-Barr virus (EBV) cause chronic fatigue syndrome? Does the type and/or amount of heparin I receive make a difference in my risk for developing HIT? If I have an HIT antibody, will it eventually go away? If I have hepatitis, should I have a \n",
       "<mark class=\"entity\" style=\"background: #7aecec; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    DCP\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">ORG</span>\n",
       "</mark>\n",
       " test performed? If I have hepatitis A, how long will I be contagious? If I have heavy menstrual periods, do I have \n",
       "<mark class=\"entity\" style=\"background: #aa9cfc; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    von Willebrand\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">PERSON</span>\n",
       "</mark>\n",
       " disease (VWD)? If I have had EBV infection, can I still get mono? If I have had dengue fever, can I get it again? If I have had a Zika infection, can I get it again? If I have had a kidney stone, what foods or drinks should I avoid ? If I have had a kidney stone, should I avoid calcium? If I have had a hepatitis A infection, can I get it again? If I have genetic testing done, will I still need to be monitored with PT/INR tests? If I have elevated cold agglutinins, is there anything I can do to make them go away or decrease them? If I have diabetes, should I have a fructosamine test? If I have diabetes, can I just test for glucose instead of ketones? If I have cardiolipin antibodies, will I definitely develop blood clots? If I have been diagnosed with lupus, will it ever go away? If I have a positive urine protein test, what other tests might be done in follow up? If I have a persistent cough and fever, why would my healthcare provider ask me where I have been traveling and what activities I have been doing? If I have liver cancer in my family, should I be tested for \n",
       "<mark class=\"entity\" style=\"background: #7aecec; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    DCP\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">ORG</span>\n",
       "</mark>\n",
       "? If I have measles or mumps and develop complications, will they go away once the infection resolves? If I have \n",
       "<mark class=\"entity\" style=\"background: #e4e7d2; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    one\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CARDINAL</span>\n",
       "</mark>\n",
       " antiphospholipid antibody, will I develop others? If I think I have an allergy, should I have a tryptase test done? If my doctor tells me to eat \n",
       "<mark class=\"entity\" style=\"background: #e4e7d2; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    100 grams\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">QUANTITY</span>\n",
       "</mark>\n",
       " of fat a day, can I vary it \n",
       "<mark class=\"entity\" style=\"background: #e4e7d2; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    between 50 and 150\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CARDINAL</span>\n",
       "</mark>\n",
       " grams? If my blood smear shows abnormal results, what additional testing might be done? If my \n",
       "<mark class=\"entity\" style=\"background: #7aecec; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    AFP\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">ORG</span>\n",
       "</mark>\n",
       " is abnormal, do I need other tests? If Lp(a) levels don't really change over my lifetime, why would my healthcare practitioner prescribe treatment? If I've had a bicarbonate (total CO2) test, why does my healthcare practitioner want to test my blood gases? If it is suspected that I have an excessive clotting disorder, what tests other than \n",
       "<mark class=\"entity\" style=\"background: #feca74; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    LA\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">GPE</span>\n",
       "</mark>\n",
       " might my doctor use to evaluate my condition? If it is possible that I have an HBV infection, will I need to have all these tests done? If I think I have an allergy, should I have a histamine test done? If I have or had \n",
       "<mark class=\"entity\" style=\"background: #7aecec; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    CMV\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">ORG</span>\n",
       "</mark>\n",
       ", can I spread it to others? If I need to go on the insulin pump, will I need a C-peptide test? If I have viral hepatitis, am I contagious? If I have undetectable HIV viral load, can I still spread the disease? If I have the same MTHFR gene mutations as a relative, why is my homocysteine level significantly different? If I have the \n",
       "<mark class=\"entity\" style=\"background: #7aecec; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    PML\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">ORG</span>\n",
       "</mark>\n",
       "-RARA gene, should my close family members be tested? If I have the \n",
       "<mark class=\"entity\" style=\"background: #feca74; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    Philadelphia\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">GPE</span>\n",
       "</mark>\n",
       " chromosome and &lt;em&gt;BCR-ABL1&lt;/em&gt; gene, should my close family members be tested? If I have the &lt;em&gt;FIP1L1-PDGFRA&lt;/em&gt; fusion gene, should my family members be tested? If I have antiphospholipid antibodies, will I definitely develop blood clots? If I have an elevated tryptase, does this mean I have mastocytosis? If my haptoglobin level is low, when will it return to normal? If I have an elevated prolactin, why is my healthcare practitioner testing my thyroid? If I am diagnosed with strep, will an anti-DNase B or \n",
       "<mark class=\"entity\" style=\"background: #7aecec; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    ASO\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">ORG</span>\n",
       "</mark>\n",
       " always be performed? If I am diagnosed with gestational diabetes, will I need to monitor my glucose levels? If I am a smoker, does an elevated \n",
       "<mark class=\"entity\" style=\"background: #7aecec; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    CEA\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">ORG</span>\n",
       "</mark>\n",
       " level mean I have cancer? If \n",
       "<mark class=\"entity\" style=\"background: #7aecec; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    HE\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">ORG</span>\n",
       "</mark>\n",
       " or \n",
       "<mark class=\"entity\" style=\"background: #7aecec; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    HES\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">ORG</span>\n",
       "</mark>\n",
       " is suspected, what other lab tests in may be done in addition to &lt;em&gt;FIP1L1-PDGFRA&lt;/em&gt;? If bicarbonate levels are too high or low, what treatments can help? If a mother has an incompatibility with \n",
       "<mark class=\"entity\" style=\"background: #e4e7d2; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    one\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CARDINAL</span>\n",
       "</mark>\n",
       " child, will she have them with all of her children? If a drop of blood on a slide contains \n",
       "<mark class=\"entity\" style=\"background: #e4e7d2; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    millions\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CARDINAL</span>\n",
       "</mark>\n",
       " of RBCs, \n",
       "<mark class=\"entity\" style=\"background: #e4e7d2; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    thousands\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CARDINAL</span>\n",
       "</mark>\n",
       " of WBCs, and \n",
       "<mark class=\"entity\" style=\"background: #e4e7d2; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    hundreds of thousands\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CARDINAL</span>\n",
       "</mark>\n",
       " of platelets, how can the laboratorian see individual cells? I am taking the drug primidone. Why is my doctor monitoring phenobarbital? I am pregnant. Will I have both \n",
       "<mark class=\"entity\" style=\"background: #e4e7d2; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    first\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">ORDINAL</span>\n",
       "</mark>\n",
       " and \n",
       "<mark class=\"entity\" style=\"background: #e4e7d2; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    second\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">ORDINAL</span>\n",
       "</mark>\n",
       " trimester screening performed? I am pregnant; will I have both \n",
       "<mark class=\"entity\" style=\"background: #e4e7d2; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    first\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">ORDINAL</span>\n",
       "</mark>\n",
       " and \n",
       "<mark class=\"entity\" style=\"background: #e4e7d2; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    second\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">ORDINAL</span>\n",
       "</mark>\n",
       " trimester screening performed? I am on anticoagulant therapy. Can I still have this test done? I am on a low-dose aspirin regimen to prevent another heart attack. Do I need to be monitored with salicylate tests? I am being treated with warfarin (\n",
       "<mark class=\"entity\" style=\"background: #aa9cfc; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    Coumadin\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">PERSON</span>\n",
       "</mark>\n",
       "). Should I avoid eating foods that are rich in vitamin K and will limiting these foods cause an increased risk of vitamin K deficiency? I am a woman, so why do I need a testosterone test? I am an alcoholic, but I have quit drinking. Will my GGT ever go back to normal? I also had a test for thyroglobulin antibodies done. Why? How would an \n",
       "<mark class=\"entity\" style=\"background: #7aecec; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    ER\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">ORG</span>\n",
       "</mark>\n",
       " physician evaluate an unconscious person or a child who is unable to tell what he or she has taken? If I am diagnosed with strep, will an \n",
       "<mark class=\"entity\" style=\"background: #7aecec; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    ASO\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">ORG</span>\n",
       "</mark>\n",
       " always be performed? If I am menopausal and on hormone replacement therapy (HRT), is there ever a need to monitor my progesterone level? If I am treated and the infection goes away, can I get another &lt;em&gt;H. pylori&lt;/em&gt; infection? If I have \n",
       "<mark class=\"entity\" style=\"background: #7aecec; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    AMA\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">ORG</span>\n",
       "</mark>\n",
       ", will the antibodies ever go away? If I have an elevated MMA, why might my doctor hesitate to diagnose me with vitamin B12 deficiency? If I have an elevated B2M, does it mean that I have been exposed to cadmium or mercury? If I have a negative NIPS with my current pregnancy, will I need to repeat it with the next baby? If I have an abnormal \n",
       "<mark class=\"entity\" style=\"background: #7aecec; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    WBC\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">ORG</span>\n",
       "</mark>\n",
       " count, what other tests might my doctor order? If I have an abnormal result on my \n",
       "<mark class=\"entity\" style=\"background: #7aecec; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    WBC\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">ORG</span>\n",
       "</mark>\n",
       " differential, what other tests might my healthcare provider order? If I have an abnormal result on my \n",
       "<mark class=\"entity\" style=\"background: #7aecec; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    CBC\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">ORG</span>\n",
       "</mark>\n",
       ", what other tests might my healthcare practitioner order as follow up? If I have an abnormal monoclonal immunoglobulin in my blood, does it mean that I have multiple myeloma or some other type of cancer? If I have a low testosterone level, will taking supplemental testosterone help? If I can't absorb vitamin \n",
       "<mark class=\"entity\" style=\"background: #7aecec; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    B12\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">ORG</span>\n",
       "</mark>\n",
       ", how can I get enough? If I have a hobby such as stained glass working but no symptoms, do I need to have a ZPP test done? If I get treated, can I get trichomoniasis again? If I get treated, can I get syphilis again? If I get treated, can I get chlamydia again? If I get a liquid biopsy, will I still need a tissue biopsy? If I develop antibodies to \n",
       "<mark class=\"entity\" style=\"background: #e4e7d2; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    one\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CARDINAL</span>\n",
       "</mark>\n",
       " type of TNF inhibitor therapy, and I am switched to a different one, will I develop antibodies to the \n",
       "<mark class=\"entity\" style=\"background: #e4e7d2; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    second\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">ORDINAL</span>\n",
       "</mark>\n",
       " TNF inhibitor? If I consume foods fortified with calcium, would it change my laboratory results? If my fibrinogen level is increased, what can I do to reduce it? If my healthcare provider thinks I have a fungal infection, why am I being tested for tuberculosis? How treatable are abnormal red blood cell counts? Is ACT ever done in the central laboratory? Is it necessary to do both blood and urine tests? Is it important to use the same lab each time I have a CA 19-9 test done? Is it important to determine which mutation I have? Is hs-CRP specific for predicting heart disease? Is \n",
       "<mark class=\"entity\" style=\"background: #7aecec; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    GBS\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">ORG</span>\n",
       "</mark>\n",
       " considered a sexually transmitted disease (STD)? Is fortifying milk and cereals with vitamin D a good practice? Is electrophoresis used for anything else? Is calcitonin ever used as a supplement? Is CA-125 always increased in ovarian cancer? Is a pleural effusion serious? Is anyone more at risk for abnormal hematocrit values? Is anyone at particular risk for low or high sodium levels? Is anyone at high risk for abnormal albumin levels? Is anyone at greater risk of abnormal hemoglobin levels? Is an eGFR always calculated when a creatinine test is ordered? Is ammonia testing used to detect or monitor ammonia poisoning? Is a home sperm count test available? Is it necessary to perform ASCA testing more than once? Abnormal structures within the red blood cell Is it necessary to repeat an \n",
       "<mark class=\"entity\" style=\"background: #7aecec; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    ALK\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">ORG</span>\n",
       "</mark>\n",
       " mutation test? Is my blood type (\n",
       "<mark class=\"entity\" style=\"background: #7aecec; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    ABO\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">ORG</span>\n",
       "</mark>\n",
       ") related to my HLA genes and antigens? Is the breath test used for other things? Is the amount of amniotic fluid present important? Is testing before treatment really necessary? Is sirolimus given to patients who receive organs other than kidneys or have other conditions? Is shingles contagious? Is sample collection critical for lupus anticoagulant (\n",
       "<mark class=\"entity\" style=\"background: #feca74; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    LA\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">GPE</span>\n",
       "</mark>\n",
       ") testing? Is progesterone used as treatment? Is mononucleosis really a &quot;kissing disease&quot;? Is it necessary to use both HE4 and CA-125? Is it safe to donate and receive blood? Is it really necessary to save all of my urine over \n",
       "<mark class=\"entity\" style=\"background: #bfe1d9; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    5 hours\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">TIME</span>\n",
       "</mark>\n",
       "? Is it really necessary to lie down before testing? Is it really necessary to follow the dietary restrictions? Is it really necessary to continue treatment for a long period of time? Is it possible to prevent a group B strep (\n",
       "<mark class=\"entity\" style=\"background: #7aecec; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    GBS\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">ORG</span>\n",
       "</mark>\n",
       ") infection in newborns? Is it ok for pregnant women and young children to eat fish? Is a haptoglobin test used for anything else? Is acetaminophen dangerous if used appropriately? If my \n",
       "<mark class=\"entity\" style=\"background: #7aecec; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    O&amp;P\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">ORG</span>\n",
       "</mark>\n",
       " is positive, what is the treatment? Is a \n",
       "<mark class=\"entity\" style=\"background: #7aecec; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    CD4\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">ORG</span>\n",
       "</mark>\n",
       " cell count used in conditions other than HIV infection? I have been taking prednisone (glucocorticoid medication) for some time. Why would suddenly stopping it cause signs and symptoms of adrenal insufficiency? I have been sick for \n",
       "<mark class=\"entity\" style=\"background: #bfe1d9; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    more than a week\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DATE</span>\n",
       "</mark>\n",
       ".  Why would my healthcare practitioner order a sputum culture now? I have a strong family history of breast cancer. Shouldn't I be screened for CA 15-3? I had a screening test for cholesterol. It was \n",
       "<mark class=\"entity\" style=\"background: #e4e7d2; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    less than 200\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CARDINAL</span>\n",
       "</mark>\n",
       " mg/dL (\n",
       "<mark class=\"entity\" style=\"background: #e4e7d2; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    5.18\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CARDINAL</span>\n",
       "</mark>\n",
       " mmol/L). Do I need a lipid panel? I had a boil on my arm and the healthcare practitioner did not do a culture of the material when he drained it. Why not? If this antibody targets CYP450 \n",
       "<mark class=\"entity\" style=\"background: #e4e7d2; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    2D6\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CARDINAL</span>\n",
       "</mark>\n",
       ", why is it called anti-liver kidney microsome-1 (anti-LKM-1)? If there are no symptoms, how will I know if I have an abnormal phosphorus level? If the level of my histone antibodies decreases, can I take my drug again? If the \n",
       "<mark class=\"entity\" style=\"background: #7aecec; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    LD\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">ORG</span>\n",
       "</mark>\n",
       " test is not specific, how can it be clinically useful? If the disease is very mild, why should I be tested? I found out I am positive for \n",
       "<mark class=\"entity\" style=\"background: #7aecec; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    HTLV\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">ORG</span>\n",
       "</mark>\n",
       ". What precautions should I take to avoid infecting others? If one of my children has CF, should my other children be tested? If \n",
       "<mark class=\"entity\" style=\"background: #e4e7d2; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    one\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CARDINAL</span>\n",
       "</mark>\n",
       " child in my family has strep throat, is everyone going to get sick? If my thyroid is removed, will I need to replace my calcitonin? If my RBC Count is out of range, what other tests might be done? If my posture is important in the outcome of the results, how can I control it? If my platelet count is abnormal, what follow-up tests might my healthcare practitioner order? I have had cholesterol tests but never an hs-CRP test. Why? I heard that some athletes may be tested for hCG. Why is that? I heard there is another test that certain people should have before taking carbamazepine. What is it? In addition to factor V \n",
       "<mark class=\"entity\" style=\"background: #feca74; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    Leiden\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">GPE</span>\n",
       "</mark>\n",
       " and PT 2010, what other tests might be done to evaluate excessive clotting? Is A1c reported the same way around the world? In addition to the blood sample for this test, I was instructed to collect a urine sample. Why? In addition to stone testing, what other lab tests might be done? In addition to SHBG, what other tests might be done? In addition to MPA levels, what other tests might be ordered? In addition to lead, \n",
       "<mark class=\"entity\" style=\"background: #7aecec; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    mercury, arsenic\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">ORG</span>\n",
       "</mark>\n",
       ", cadmium and chromium, what are some other metals that may be tested? In addition to growth hormone testing, what other laboratory tests might be done? In addition to \n",
       "<mark class=\"entity\" style=\"background: #7aecec; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    ASO\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">ORG</span>\n",
       "</mark>\n",
       ", what other testing might be done? I know eating foods high in iron or taking iron supplements will increase my iron level, but will it also increase my ferritin level? In addition to a reticulocyte count, what other tests may be done? In addition to a \n",
       "<mark class=\"entity\" style=\"background: #7aecec; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    PTT\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">ORG</span>\n",
       "</mark>\n",
       ", what other tests might be done? In addition to acetaminophen levels, what other lab tests might be done? Im having a hard time getting pregnant. What tests do I need? I'm having a hard time getting pregnant. What tests do I need? Im blood type O. Do I have a chance of having a baby with ABO hemolytic disease of the newborn? I'm a woman who has had the \n",
       "<mark class=\"entity\" style=\"background: #7aecec; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    HPV\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">ORG</span>\n",
       "</mark>\n",
       " vaccine. Do I need cervical cancer screening? How widely available are liquid biopsies? How soon after exposure to the virus do symptoms appear? Does the vaccine have any risks? How bad is the pain with kidney stones? How can the healthcare practitioner determine the sex of a baby with sex organs that are not clearly male or female? How can the doctor determine the sex of a baby with sex organs that are not clearly male or female? How can syphilis be prevented? How can I test my soil, water, or the paint on my house for heavy metals? How can I tell if my cytomegalovirus (\n",
       "<mark class=\"entity\" style=\"background: #7aecec; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    CMV\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">ORG</span>\n",
       "</mark>\n",
       ") has reactivated? How can I tell if I am contagious and can spread the infection to others? How can I protect myself from getting a MRSA infection? How can I prevent kidney stones? How can I prevent a respiratory infection? How can I prevent a parasitic infection? How can I prevent a \n",
       "<mark class=\"entity\" style=\"background: #7aecec; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    GI\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">ORG</span>\n",
       "</mark>\n",
       " infection? How can I lower my VLDL-C level? How can I determine my risk of developing a blood clot? How can I decrease my LDL-P? How can I change my \n",
       "<mark class=\"entity\" style=\"background: #7aecec; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    PTT\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">ORG</span>\n",
       "</mark>\n",
       "? How can HPV be prevented? How can chlamydia be prevented? How can trichomoniasis be prevented? How common are B-cell gene rearrangements? How common are T-cell lymphomas? How does BUN change with age? How do microbes become resistant to antimicrobial drugs? How do I tell if a high cortisol level isn't just from stress? How do I know what to eat and where can I get help? How does the test that I do at home myself compare with the results of a test done in a lab? How does the healthcare practitioner tell whether a tumor is benign or cancerous? How does my healthcare practitioner tell whether a tumor is benign or cancerous? How does diet affect creatinine levels? How does a healthcare practitioner locate the \n",
       "<mark class=\"entity\" style=\"background: #7aecec; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    carcinoid\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">ORG</span>\n",
       "</mark>\n",
       " tumor? How common is alpha-1 antitrypsin deficiency? How does a healthcare practitioner locate the \n",
       "<mark class=\"entity\" style=\"background: #7aecec; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    carcinoid\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">ORG</span>\n",
       "</mark>\n",
       " or neuroendocrine tumor? How does a healthcare practitioner find a stone in my urinary tract? How does a bone marrow aspiration and/or biopsy compare with a bone marrow collection for donation? How did I get infected with &lt;em&gt;H. pylori&lt;/em&gt;? How deadly are strokes? How could I have gotten the virus without knowing it? How common is heart failure? How can a diabetes educator help me? How are vitamin A deficiencies treated? How do they decide what strains are in the vaccine each year? How are they used? Do \n",
       "<mark class=\"entity\" style=\"background: #7aecec; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    RBC\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">ORG</span>\n",
       "</mark>\n",
       " antibodies go away? Do \n",
       "<mark class=\"entity\" style=\"background: #7aecec; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    RBC\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">ORG</span>\n",
       "</mark>\n",
       " antibodies affect blood donation? Do other group A strep cause other types of infections? Do I really need to save all of my urine for \n",
       "<mark class=\"entity\" style=\"background: #bfe1d9; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    24 hours\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">TIME</span>\n",
       "</mark>\n",
       "? Do I really have to filter all of my urine for this test? Do I need to tell other healthcare practitioners that I am on TNF inhibitor therapy? Do I need to tell my other healthcare providers that I am receiving heparin? Do I need to tell a new healthcare provider that I have a G6PD deficiency if I do not have any symptoms? Do I need to stop taking any medications or are there any dietary restrictions for this test? Do I need to let my other healthcare providers know that I am taking methotrexate? Do I need to know my blood type? Do I need to have all \n",
       "<mark class=\"entity\" style=\"background: #e4e7d2; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    three\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CARDINAL</span>\n",
       "</mark>\n",
       " types of AAT testing? Do I need to follow a gluten-free diet if I have been diagnosed with celiac disease but have never had any symptoms? Do I need to fast for a fructosamine test? Do I need both tests (blood and urine) or is one better than the other? Do healthcare practitioners test \n",
       "<mark class=\"entity\" style=\"background: #7aecec; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    TSH\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">ORG</span>\n",
       "</mark>\n",
       " during pregnancy? Does this test detect all genetic causes of cystic fibrosis? Do silver teeth fillings contain mercury? Do some medicines interact badly with vancomycin? Do some people have an inherited (genetic) risk of abnormal bilirubin levels? How are classifications of body weight determined? How are the tests used? How are the newly approved oral anticoagulation drugs monitored? How are testosterone levels used to monitor transgender individuals? How are Shiga toxin-producing E. coli infections of the digestive tract treated? How are pituitary tumors that produce \n",
       "<mark class=\"entity\" style=\"background: #aa9cfc; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    prolactin\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">PERSON</span>\n",
       "</mark>\n",
       " (prolactinoma) treated? How are ovarian tumors treated? How are deep vein thrombosis (DVT) and/or venous thromboembolism (VTE) treated? How are abnormal \n",
       "<mark class=\"entity\" style=\"background: #feca74; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    GH\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">GPE</span>\n",
       "</mark>\n",
       " levels treated? Do the autoantibodies \n",
       "<mark class=\"entity\" style=\"background: #7aecec; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    ICA\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">ORG</span>\n",
       "</mark>\n",
       ", \n",
       "<mark class=\"entity\" style=\"background: #7aecec; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    IAA\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">ORG</span>\n",
       "</mark>\n",
       ", \n",
       "<mark class=\"entity\" style=\"background: #7aecec; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    GADA\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">ORG</span>\n",
       "</mark>\n",
       ", IA-2A or ZnT8A destroy the beta cells? \n",
       "<mark class=\"entity\" style=\"background: #aa9cfc; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    Hemoglobin Reference Range Hematocrit Reference Range Glucose For\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">PERSON</span>\n",
       "</mark>\n",
       " Health Professionals: Table of Protein Groups Examples of Drugs of Abuse Epithelial cells Eosinophils How do people get exposed? Is touching these products enough to raise my blood lead level? How do you treat abnormal bilirubin levels and/or jaundice? How serious is a case of infectious mononucleosis? How long does it take for AMH results? How long will I need to be on mycophenolate? How long will I need to be on lithium? How long will I need to be on levetiracetam? How long will I need to be on digoxin? How long will I need to be on cyclosporine? How long will I need to be on carbamazepine? How long will I have to receive heparin treatment? How long will a drug test detect \n",
       "<mark class=\"entity\" style=\"background: #7aecec; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    THC\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">ORG</span>\n",
       "</mark>\n",
       " after marijuana use? How long should I stay away from other people if I have a positive test result? How long is someone usually treated with heparin? How long do I have to be monitored? How long does it take to get results from a syphilis test? How long does it take for results to become available? How long does it take for \n",
       "<mark class=\"entity\" style=\"background: #feca74; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    PD-L1\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">GPE</span>\n",
       "</mark>\n",
       " testing results? How long does it take for \n",
       "<mark class=\"entity\" style=\"background: #7aecec; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    NIPS\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">ORG</span>\n",
       "</mark>\n",
       " results? How long does it take for &lt;em&gt;JAK2&lt;/em&gt; mutation test results? How long does it take for EGFR testing results? How long will I need to be on phenytoin? How long will I need to be on sirolimus? How long will I need to be on tacrolimus? How long will it take for test results? How much vitamin D should I be getting each day? How many days after a miscarriage would it take for a urine pregnancy test to show a negative result? How long will my phenobarbital level have to be monitored? How long will it take to get the results of my gastrin test? How long will it take to get results? How long will it take to get my results? How long will it take for the medicine to work? How long will it take for pregnenolone results? How long will I need to be on valproic acid? How long will it take for \n",
       "<mark class=\"entity\" style=\"background: #7aecec; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    PML\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">ORG</span>\n",
       "</mark>\n",
       "-RARA testing results? How long will it take for my results to be available? How long will it take for my ESR result? How long will it take for my calprotectin results? How long will it take for HLA-B27 results? How long will it take for androstenedione test results? How long will it take for \n",
       "<mark class=\"entity\" style=\"background: #e4e7d2; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    17\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CARDINAL</span>\n",
       "</mark>\n",
       "-hydroxyprogesterone results? How long does it take for \n",
       "<mark class=\"entity\" style=\"background: #7aecec; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    CALR\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">ORG</span>\n",
       "</mark>\n",
       " mutation test results? How long does a premature neonate have to take caffeine? How effective is the skin test for allergies? How long does antibiotic treatment for strep throat usually last? How is estimated Average Glucose (eAG) calculated? How is \n",
       "<mark class=\"entity\" style=\"background: #aa9cfc; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    Epstein-Barr\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">PERSON</span>\n",
       "</mark>\n",
       " virus (EBV) infection or infectious mononucleosis (mono) treated? How is diabetes treated? How is diabetes insipidus different than diabetes mellitus? How is cryoglobulinemia treated? How is chlamydia treated? How is a whooping cough treated? How is a salicylate overdose treated? How is a protein C or protein S deficiency treated? How is a person with lupus anticoagulant treated? How is an insulinoma treated? How is an eGFR calculated? How is an acetaminophen overdose treated? How is Alzheimer disease definitively diagnosed? How fast does \n",
       "<mark class=\"entity\" style=\"background: #7aecec; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    PBC\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">ORG</span>\n",
       "</mark>\n",
       " progress? How else might my health practitioner use the measurement of SHBG levels in my care? How else might my doctor evaluate the cell production in my bone marrow? How is gestational diabetes treated? How is heart failure treated? How is hepatitis A treated? How is the blood smear used? How large are kidney stones? How is valproic acid taken? How is trichomoniasis treated? How is transferrin saturation calculated? How is the testing used? How is the serum osmolal gap calculated? How is the \n",
       "<mark class=\"entity\" style=\"background: #7aecec; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    BMP\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">ORG</span>\n",
       "</mark>\n",
       " different than the \n",
       "<mark class=\"entity\" style=\"background: #7aecec; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    CMP\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">ORG</span>\n",
       "</mark>\n",
       " and why would my doctor order \n",
       "<mark class=\"entity\" style=\"background: #e4e7d2; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    one\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CARDINAL</span>\n",
       "</mark>\n",
       " over the other? How is someone exposed to toxic metals? How is hepatitis B treated? How is phenytoin taken? How is non-HDL cholesterol calculated? How is leptin deficiency treated? How is hypoglycemia diagnosed? How is \n",
       "<mark class=\"entity\" style=\"background: #7aecec; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    HPV\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">ORG</span>\n",
       "</mark>\n",
       " treated? How is HIV treated? How is HIV infection diagnosed? Would this testing and drug therapy be useful for other types of cancer?</div>\n",
       "</figure>\n",
       "</body>\n",
       "</html></span>"
      ],
      "text/plain": [
       "<IPython.core.display.HTML object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "\n",
      "Using the 'ent' visualizer\n",
      "Serving on http://0.0.0.0:5000 ...\n",
      "\n",
      "Shutting down server on port 5000.\n"
     ]
    }
   ],
   "source": [
    "displacy.serve(doc, style='ent')"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "id": "amazing-remedy",
   "metadata": {},
   "outputs": [],
   "source": []
  }
 ],
 "metadata": {
  "kernelspec": {
   "display_name": "Python 3",
   "language": "python",
   "name": "python3"
  },
  "language_info": {
   "codemirror_mode": {
    "name": "ipython",
    "version": 3
   },
   "file_extension": ".py",
   "mimetype": "text/x-python",
   "name": "python",
   "nbconvert_exporter": "python",
   "pygments_lexer": "ipython3",
   "version": "3.8.7"
  }
 },
 "nbformat": 4,
 "nbformat_minor": 5
}
